{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 770, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T00:31:21Z", "timestamp": 1574209881151}, "reference-count": 0, "publisher": "Proceedings of the National Academy of Sciences", "issue": "23", "content-domain": {"domain": ["pnas.org"], "crossmark-restriction": true}, "short-container-title": ["Proceedings of the National Academy of Sciences"], "published-print": {"date-parts": [[1988, 12, 1]]}, "DOI": "10.1073/pnas.85.23.9248", "type": "journal-article", "created": {"date-parts": [[2006, 5, 31]], "date-time": "2006-05-31T10:47:04Z", "timestamp": 1149072424000}, "page": "9248-9252", "update-policy": "http://dx.doi.org/10.1073/pnas.cm10313", "source": "Crossref", "is-referenced-by-count": 99, "title": ["Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1."], "prefix": "10.1073", "volume": "85", "author": [{"given": "D. C.", "family": "Montefiori", "sequence": "first", "affiliation": []}, {"given": "W. E.", "family": "Robinson", "sequence": "additional", "affiliation": []}, {"given": "W. M.", "family": "Mitchell", "sequence": "additional", "affiliation": []}], "member": "341", "container-title": ["Proceedings of the National Academy of Sciences"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1073/pnas.85.23.9248", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 3, 30]], "date-time": "2017-03-30T20:55:16Z", "timestamp": 1490907316000}, "score": 44.415886, "issued": {"date-parts": [[1988, 12, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1988, 12, 1]]}, "issue": "23"}, "URL": "http://dx.doi.org/10.1073/pnas.85.23.9248", "ISSN": ["0027-8424", "1091-6490"], "issn-type": [{"value": "0027-8424", "type": "print"}, {"value": "1091-6490", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:21:08Z", "timestamp": 1574504468494}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 6, 30]]}, "DOI": "10.3410/f.1115404.572227", "type": "dataset", "created": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T04:31:24Z", "timestamp": 1347942684000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection."], "prefix": "10.3410", "author": [{"given": "David", "family": "Montefiori", "sequence": "first", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2008, 6, 23]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T04:32:13Z", "timestamp": 1347942733000}, "score": 35.849255, "issued": {"date-parts": [[2008, 6, 23]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.1115404.572227"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T06:26:01Z", "timestamp": 1575095161622}, "reference-count": 22, "publisher": "Elsevier BV", "issue": "8589", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 4, 1]], "date-time": "1988-04-01T00:00:00Z", "timestamp": 575856000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[1988, 4]]}, "DOI": "10.1016/s0140-6736(88)91657-1", "type": "journal-article", "created": {"date-parts": [[2003, 10, 9]], "date-time": "2003-10-09T07:28:31Z", "timestamp": 1065684511000}, "page": "790-794", "source": "Crossref", "is-referenced-by-count": 212, "title": ["ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION"], "prefix": "10.1016", "volume": "331", "author": [{"suffix": "JR", "given": "W.Edward", "family": "Robinson", "sequence": "first", "affiliation": []}, {"given": "DavidC.", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "WilliamM.", "family": "Mitchell", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673688916571?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673688916571?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 22]], "date-time": "2019-02-22T13:57:53Z", "timestamp": 1550843873000}, "score": 35.290997, "issued": {"date-parts": [[1988, 4]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[1988, 4]]}, "issue": "8589"}, "alternative-id": ["S0140673688916571"], "URL": "http://dx.doi.org/10.1016/s0140-6736(88)91657-1", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T17:06:59Z", "timestamp": 1575047219435}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 12, 1]], "date-time": "1996-12-01T00:00:00Z", "timestamp": 849398400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 7, 17]], "date-time": "2013-07-17T00:00:00Z", "timestamp": 1374019200000}, "delay-in-days": 6072, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Virology"], "published-print": {"date-parts": [[1996, 12]]}, "DOI": "10.1006/viro.1996.0623", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T13:00:16Z", "timestamp": 1032440416000}, "page": "13-21", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Complement-Activating Antibodies in Sera from Infected Individuals and Vaccinated Volunteers That Target Human Immunodeficiency Virus Type 1 to Complement Receptor Type 1 (CR1, CD35)"], "prefix": "10.1006", "volume": "226", "author": [{"given": "Jintao", "family": "Zhou", "sequence": "first", "affiliation": []}, {"given": "David C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0042682296906236?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0042682296906236?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T22:27:59Z", "timestamp": 1557354479000}, "score": 35.151688, "issued": {"date-parts": [[1996, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 12]]}, "issue": "1"}, "alternative-id": ["S0042682296906236"], "URL": "http://dx.doi.org/10.1006/viro.1996.0623", "ISSN": ["0042-6822"], "issn-type": [{"value": "0042-6822", "type": "print"}], "subject": ["Virology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:54:29Z", "timestamp": 1574286869157}, "reference-count": 23, "publisher": "Mary Ann Liebert Inc", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["AIDS Research and Human Retroviruses"], "published-print": {"date-parts": [[1987, 1]]}, "DOI": "10.1089/aid.1987.3.265", "type": "journal-article", "created": {"date-parts": [[2009, 3, 16]], "date-time": "2009-03-16T14:26:46Z", "timestamp": 1237213606000}, "page": "265-282", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Evidence That Mannosyl Residues Are Involved in Human Immunodeficiency Virus Type 1 (HIV-1) Pathogenesis"], "prefix": "10.1089", "volume": "3", "author": [{"suffix": "JR.", "given": "W. EDWARD", "family": "ROBINSON", "sequence": "first", "affiliation": []}, {"given": "DAVID C.", "family": "MONTEFIORI", "sequence": "additional", "affiliation": []}, {"given": "WILLIAM M.", "family": "MITCHELL", "sequence": "additional", "affiliation": []}], "member": "278", "container-title": ["AIDS Research and Human Retroviruses"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/aid.1987.3.265", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 16]], "date-time": "2018-07-16T21:51:03Z", "timestamp": 1531777863000}, "score": 33.609627, "issued": {"date-parts": [[1987, 1]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[1987, 1]]}, "issue": "3"}, "alternative-id": ["10.1089/aid.1987.3.265"], "URL": "http://dx.doi.org/10.1089/aid.1987.3.265", "ISSN": ["0889-2229", "1931-8405"], "issn-type": [{"value": "0889-2229", "type": "print"}, {"value": "1931-8405", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:47:01Z", "timestamp": 1574279221664}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J INFECT DIS"], "published-print": {"date-parts": [[1997, 11]]}, "DOI": "10.1086/514134", "type": "journal-article", "created": {"date-parts": [[2009, 2, 7]], "date-time": "2009-02-07T07:48:22Z", "timestamp": 1233992902000}, "page": "1410-1410", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Neutralization Assays using the BZ167 Strain of Human Immunodeficiency Virus Type 1"], "prefix": "10.1093", "volume": "176", "author": [{"given": "John\u00a0P.", "family": "Moore", "sequence": "first", "affiliation": []}, {"given": "David\u00a0C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["The Journal of Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/jid/article-pdf/176/5/1410/2477936/176-5-1410.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T12:34:20Z", "timestamp": 1503491660000}, "score": 31.944368, "issued": {"date-parts": [[1997, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 11]]}, "issue": "5"}, "alternative-id": ["10.1086/514134"], "URL": "http://dx.doi.org/10.1086/514134", "ISSN": ["0022-1899", "1537-6613"], "issn-type": [{"value": "0022-1899", "type": "print"}, {"value": "1537-6613", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:35:21Z", "timestamp": 1574123721646}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1990, 4, 1]], "date-time": "1990-04-01T00:00:00Z", "timestamp": 638928000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Hospital Infection"], "published-print": {"date-parts": [[1990, 4]]}, "DOI": "10.1016/0195-6701(90)90036-n", "type": "journal-article", "created": {"date-parts": [[2004, 4, 28]], "date-time": "2004-04-28T12:31:00Z", "timestamp": 1083155460000}, "page": "279-282", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Effective inactivation of human immunodeficiency virus with chlorhexidine antiseptics containing detergents and alcohol"], "prefix": "10.1016", "volume": "15", "author": [{"given": "D", "family": "Montefiori", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Hospital Infection"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0195-6701(90)90036-N?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0195-6701(90)90036-N?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T05:52:45Z", "timestamp": 1549777965000}, "score": 31.454918, "issued": {"date-parts": [[1990, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 4]]}, "issue": "3"}, "alternative-id": ["0195-6701(90)90036-N"], "URL": "http://dx.doi.org/10.1016/0195-6701(90)90036-n", "ISSN": ["0195-6701"], "issn-type": [{"value": "0195-6701", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:47:07Z", "timestamp": 1574149627879}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2003, 2, 1]]}, "DOI": "10.1128/jvi.77.3.2046-2055.2003", "type": "journal-article", "created": {"date-parts": [[2003, 1, 13]], "date-time": "2003-01-13T23:04:06Z", "timestamp": 1042499046000}, "page": "2046-2055", "source": "Crossref", "is-referenced-by-count": 69, "title": ["Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d"], "prefix": "10.1128", "volume": "77", "author": [{"given": "T. D.", "family": "Green", "sequence": "first", "affiliation": []}, {"given": "D. C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "T. M.", "family": "Ross", "sequence": "additional", "affiliation": []}], "member": "235", "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.77.3.2046-2055.2003", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T09:16:55Z", "timestamp": 1482484615000}, "score": 30.212688, "issued": {"date-parts": [[2003, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 2, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1128/jvi.77.3.2046-2055.2003", "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:51:56Z", "timestamp": 1574153516025}, "reference-count": 20, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1987, 12, 1]], "date-time": "1987-12-01T00:00:00Z", "timestamp": 565315200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical and Biophysical Research Communications"], "published-print": {"date-parts": [[1987, 12]]}, "DOI": "10.1016/0006-291x(87)90423-2", "type": "journal-article", "created": {"date-parts": [[2004, 12, 3]], "date-time": "2004-12-03T17:41:45Z", "timestamp": 1102095705000}, "page": "693-699", "source": "Crossref", "is-referenced-by-count": 22, "title": ["A Human Immunodeficiency Virus type 1 (HIV-1) infection-enhancing factor in seropositive sera"], "prefix": "10.1016", "volume": "149", "author": [{"suffix": "Jr.", "given": "W.Edward", "family": "Robinson", "sequence": "first", "affiliation": []}, {"given": "David C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "William M.", "family": "Mitchell", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical and Biophysical Research Communications"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006291X87904232?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006291X87904232?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T15:57:00Z", "timestamp": 1549036620000}, "score": 30.212688, "issued": {"date-parts": [[1987, 12]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[1987, 12]]}, "issue": "2"}, "alternative-id": ["0006291X87904232"], "URL": "http://dx.doi.org/10.1016/0006-291x(87)90423-2", "ISSN": ["0006-291X"], "issn-type": [{"value": "0006-291X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:12:21Z", "timestamp": 1575231141547}, "reference-count": 8, "publisher": "Wiley", "issue": "S1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6697, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997, 5]]}, "DOI": "10.1111/j.1601-0825.1997.tb00379.x", "type": "journal-article", "created": {"date-parts": [[2013, 6, 4]], "date-time": "2013-06-04T11:13:24Z", "timestamp": 1370344404000}, "page": "S70-S72", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1"], "prefix": "10.1111", "volume": "3", "author": [{"given": "DC", "family": "Shugars", "sequence": "first", "affiliation": []}, {"given": "DL", "family": "Sauls", "sequence": "additional", "affiliation": []}, {"given": "JB", "family": "Weinberg", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2013, 6, 4]]}, "reference": [{"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB1|cit1", "first-page": "284", "article-title": "Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone", "volume": "59", "author": "Adachi", "year": "1986", "journal-title": "J Virol"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB2|cit2", "first-page": "4395", "article-title": "A novel mode of human immunodeficiency virus type-1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes", "volume": "67", "author": "Asjo", "year": "1993", "journal-title": "J Virol"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB3|cit3", "first-page": "239", "article-title": "Isolation and properties of moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase", "volume": "38", "author": "Goff", "year": "1981", "journal-title": "J Virol"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1177/10454411930040032901", "article-title": "HIV in the oral cavity: virus. viral inhibitory activity, and antiviral antibodies: A review", "volume": "4", "author": "Malamud", "year": "1993", "journal-title": "Crit Rev Oral Biol Med"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1172/JCI118056", "article-title": "Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-HIV-1 activity in vitro", "volume": "96", "author": "McNeely", "year": "1995", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1126/science.2371565", "article-title": "Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor", "volume": "249", "author": "Rice", "year": "1990", "journal-title": "Science"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB7|cit7", "first-page": "114", "article-title": "Secretory leukocyte protease inhibitor targets an early event in HIV infection", "volume": "75", "author": "Shugars", "year": "1996", "journal-title": "J Dent Res"}, {"key": "10.1111/j.1601-0825.1997.tb00379.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1002/jmr.300070105", "article-title": "Selective oxidation of methionyl residues in the human recombinant secretory leukocyte proteinase inhibitor: Effect on the inhibitory binding properties", "volume": "7", "author": "Tomoova", "year": "1994", "journal-title": "J Mol Recognition"}], "container-title": ["Oral Diseases"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1601-0825.1997.tb00379.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T14:07:50Z", "timestamp": 1498054070000}, "score": 29.437428, "issued": {"date-parts": [[1997, 5]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[1997, 5]]}, "issue": "S1"}, "URL": "http://dx.doi.org/10.1111/j.1601-0825.1997.tb00379.x", "relation": {"cites": []}, "ISSN": ["1354-523X"], "issn-type": [{"value": "1354-523X", "type": "print"}], "subject": ["Otorhinolaryngology", "General Dentistry"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:15:12Z", "timestamp": 1574370912045}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "15", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2008, 8, 1]]}, "DOI": "10.1128/jvi.00562-08", "type": "journal-article", "created": {"date-parts": [[2008, 5, 22]], "date-time": "2008-05-22T00:54:00Z", "timestamp": 1211417640000}, "page": "7369-7378", "source": "Crossref", "is-referenced-by-count": 57, "title": ["Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination"], "prefix": "10.1128", "volume": "82", "author": [{"given": "M.", "family": "Vaine", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "E. T.", "family": "Crooks", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "D. C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Binley", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Lu", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2008, 5, 21]]}, "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.00562-08", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T13:08:00Z", "timestamp": 1482498480000}, "score": 29.105894, "issued": {"date-parts": [[2008, 5, 21]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2008, 7, 11]]}, "published-print": {"date-parts": [[2008, 8, 1]]}, "issue": "15"}, "URL": "http://dx.doi.org/10.1128/jvi.00562-08", "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:14:57Z", "timestamp": 1574147697479}, "reference-count": 42, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1991, 1, 1]], "date-time": "1991-01-01T00:00:00Z", "timestamp": 662688000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Antiviral Research"], "published-print": {"date-parts": [[1991, 1]]}, "DOI": "10.1016/0166-3542(91)90037-r", "type": "journal-article", "created": {"date-parts": [[2002, 12, 27]], "date-time": "2002-12-27T22:31:36Z", "timestamp": 1041028296000}, "page": "11-25", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Selective antiviral activity of synthetic soluble l-tyrosine and l-dopa melanins against human immunodeficiency virus in vitro"], "prefix": "10.1016", "volume": "15", "author": [{"given": "David C.", "family": "Montefiori", "sequence": "first", "affiliation": []}, {"given": "Jiying", "family": "Zhou", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Antiviral Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:016635429190037R?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:016635429190037R?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 31]], "date-time": "2019-03-31T10:22:29Z", "timestamp": 1554027749000}, "score": 28.909264, "issued": {"date-parts": [[1991, 1]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[1991, 1]]}, "issue": "1"}, "alternative-id": ["016635429190037R"], "URL": "http://dx.doi.org/10.1016/0166-3542(91)90037-r", "ISSN": ["0166-3542"], "issn-type": [{"value": "0166-3542", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:08:10Z", "timestamp": 1574122090519}, "reference-count": 37, "publisher": "Mary Ann Liebert Inc", "issue": "18", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["AIDS Research and Human Retroviruses"], "published-print": {"date-parts": [[2001, 12, 10]]}, "DOI": "10.1089/08892220152741405", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T22:08:35Z", "timestamp": 1027721315000}, "page": "1705-1714", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Resistance to Neutralizing Antibody and Expanded Coreceptor Usage Are Associated with Human Immunodeficiency Virus Type 1 Isolates Derived from Chimpanzees with Pathogenic Infections"], "prefix": "10.1089", "volume": "17", "author": [{"given": "Laure", "family": "Juompan", "sequence": "first", "affiliation": [{"name": "Division of Microbiology and Immunology, Yerkes Regional Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30322"}]}, {"given": "Jiying", "family": "Zhou", "sequence": "additional", "affiliation": [{"name": "Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710"}]}, {"given": "David C.", "family": "Montefiori", "sequence": "additional", "affiliation": [{"name": "Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710"}]}, {"given": "Francis J.", "family": "Novembre", "sequence": "additional", "affiliation": [{"name": "Division of Microbiology and Immunology, Yerkes Regional Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30322          and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322"}]}], "member": "278", "container-title": ["AIDS Research and Human Retroviruses"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/08892220152741405", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 16]], "date-time": "2018-07-16T21:30:16Z", "timestamp": 1531776616000}, "score": 28.377735, "issued": {"date-parts": [[2001, 12, 10]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2001, 12, 10]]}, "issue": "18"}, "alternative-id": ["10.1089/08892220152741405"], "URL": "http://dx.doi.org/10.1089/08892220152741405", "ISSN": ["0889-2229", "1931-8405"], "issn-type": [{"value": "0889-2229", "type": "print"}, {"value": "1931-8405", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:36:18Z", "timestamp": 1574120178584}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J INFECT DIS"], "published-print": {"date-parts": [[1999, 5]]}, "DOI": "10.1086/314711", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T18:58:45Z", "timestamp": 1027709925000}, "page": "1264-1267", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Neutralization Escape in Human Immunodeficiency Virus Type 1\u2013Infected Long\u2010Term Nonprogressors"], "prefix": "10.1093", "volume": "179", "author": [{"given": "Alice\u00a0P.", "family": "Bradney", "sequence": "first", "affiliation": []}, {"given": "Susan", "family": "Scheer", "sequence": "additional", "affiliation": []}, {"given": "John\u00a0M.", "family": "Crawford", "sequence": "additional", "affiliation": []}, {"given": "Susan\u00a0P.", "family": "Buchbinder", "sequence": "additional", "affiliation": []}, {"given": "David\u00a0C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["The Journal of Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/jid/article-pdf/179/5/1264/17992619/179-5-1264.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T15:20:09Z", "timestamp": 1503501609000}, "score": 28.05915, "issued": {"date-parts": [[1999, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 5]]}, "issue": "5"}, "alternative-id": ["10.1086/314711"], "URL": "http://dx.doi.org/10.1086/314711", "ISSN": ["0022-1899", "1537-6613"], "issn-type": [{"value": "0022-1899", "type": "print"}, {"value": "1537-6613", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:31:33Z", "timestamp": 1574235093062}, "reference-count": 87, "publisher": "Elsevier BV", "issue": "27", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 6, 1]], "date-time": "2007-06-01T00:00:00Z", "timestamp": 1180656000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Vaccine"], "published-print": {"date-parts": [[2007, 6]]}, "DOI": "10.1016/j.vaccine.2006.09.071", "type": "journal-article", "created": {"date-parts": [[2006, 10, 10]], "date-time": "2006-10-10T11:25:09Z", "timestamp": 1160479509000}, "page": "5102-5114", "source": "Crossref", "is-referenced-by-count": 41, "title": ["Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Mikyung", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Zhisong", "family": "Qiao", "sequence": "additional", "affiliation": []}, {"given": "Jessica", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "David", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "Ellis L.", "family": "Reinherz", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Vaccine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0264410X0601053X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0264410X0601053X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 12]], "date-time": "2019-01-12T15:20:22Z", "timestamp": 1547306422000}, "score": 28.05915, "issued": {"date-parts": [[2007, 6]]}, "references-count": 87, "journal-issue": {"published-print": {"date-parts": [[2007, 6]]}, "issue": "27"}, "alternative-id": ["S0264410X0601053X"], "URL": "http://dx.doi.org/10.1016/j.vaccine.2006.09.071", "ISSN": ["0264-410X"], "issn-type": [{"value": "0264-410X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:20:23Z", "timestamp": 1574504423979}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 9, 23]]}, "DOI": "10.3410/f.1123780.580863", "type": "dataset", "created": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T01:41:10Z", "timestamp": 1347932470000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo."], "prefix": "10.3410", "author": [{"given": "David", "family": "Montefiori", "sequence": "first", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2008, 9, 21]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2012, 9, 18]], "date-time": "2012-09-18T01:42:07Z", "timestamp": 1347932527000}, "score": 27.863941, "issued": {"date-parts": [[2008, 9, 21]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.1123780.580863"}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T05:03:23Z", "timestamp": 1576645403769}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "15", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2009, 8, 1]]}, "DOI": "10.1128/jvi.00656-09", "type": "journal-article", "created": {"date-parts": [[2009, 5, 21]], "date-time": "2009-05-21T00:46:31Z", "timestamp": 1242866791000}, "page": "7397-7410", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41"], "prefix": "10.1128", "volume": "83", "author": [{"given": "L. G.", "family": "Perez", "sequence": "first", "affiliation": []}, {"given": "M. R.", "family": "Costa", "sequence": "additional", "affiliation": []}, {"given": "C. A.", "family": "Todd", "sequence": "additional", "affiliation": []}, {"given": "B. F.", "family": "Haynes", "sequence": "additional", "affiliation": []}, {"given": "D. C.", "family": "Montefiori", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2009, 5, 20]]}, "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.00656-09", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T09:30:17Z", "timestamp": 1482485417000}, "score": 27.24592, "issued": {"date-parts": [[2009, 5, 20]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 7]]}, "published-print": {"date-parts": [[2009, 8, 1]]}, "issue": "15"}, "URL": "http://dx.doi.org/10.1128/jvi.00656-09", "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:06:33Z", "timestamp": 1574395593239}, "publisher-location": "Berlin, Heidelberg", "reference-count": 176, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642645938", "type": "print"}, {"value": "9783642608674", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997]]}, "DOI": "10.1007/978-3-642-60867-4_9", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 6]], "date-time": "2011-09-06T15:34:09Z", "timestamp": 1315323249000}, "page": "119-138", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Role of complement and Fc receptors in the pathogenesis of HIV-1 infection"], "prefix": "10.1007", "author": [{"given": "David C.", "family": "Montefiori", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "9_CR1", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0065-2776(08)60654-9", "volume": "46", "author": "JM Ahearn", "year": "1989", "unstructured": "Ahearn JM, Fearon DT (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46: 183", "journal-title": "Adv Immunol"}, {"key": "9_CR2", "first-page": "107", "volume": "4", "author": "J Albert", "year": "1990", "unstructured": "Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, Nystrom G, Fenyo EM (1990) Rapid development of isolate-specific neutralizing antibodies after primary HIV-1-infection and consequent emergence of virus variants which resist neutralization by autologous sera. J Acquir Immune Defic Syndr 4: 107", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR3", "doi-asserted-by": "crossref", "first-page": "1091", "DOI": "10.1126/science.2986290", "volume": "228", "author": "JS Allan", "year": "1985", "unstructured": "Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M (1985) Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228: 1091", "journal-title": "Science"}, {"key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1126/science.1470916", "volume": "258", "author": "LO Arthur", "year": "1991", "unstructured": "Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann J-C, Henderson LE (1991) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258: 1935", "journal-title": "Science"}, {"key": "9_CR5", "first-page": "3697", "volume": "140", "author": "JD Ashwell", "year": "1988", "unstructured": "Ashwell JD (1988) Are B lymphocytes the principal antigen-presenting cells in vivo? J Immunol 140: 3697", "journal-title": "J Immunol"}, {"key": "9_CR6", "first-page": "35", "volume": "6", "author": "LJ Bakker", "year": "1992", "unstructured": "Bakker LJ, Nottet HSLM, Vos NM de, Graaf L de, Strijp JAG van, Visser MR, Verhoef J (1992) Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes. J Acquir Immune Defic Syndr 6: 35", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1016/0042-6822(86)90392-2", "volume": "152", "author": "B Banapour", "year": "1986", "unstructured": "Banapour B, Sernatinger J, Levy JA (1986) The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 152: 268", "journal-title": "Virology"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "1142", "DOI": "10.1093/clinids/10.6.1142", "volume": "10", "author": "BS Bender", "year": "1988", "unstructured": "Bender BS, Davidson BL, Kline R, Brown C, Quinn TC (1988) Role of the mononuclear phagocytic system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis 10: 1142", "journal-title": "Rev Infect Dis"}, {"key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1016/0140-6736(91)92513-2", "volume": "337", "author": "V Beral", "year": "1991", "unstructured": "Beral V, Peterman T, Berkelman R, Jaffe H (1991) AIDS-associated non-Hodgkin lymphoma. Lancet 337: 805", "journal-title": "Lancet"}, {"key": "9_CR10", "first-page": "2569", "volume": "141", "author": "JF Bohnsack", "year": "1988", "unstructured": "Bohnsack JF, Cooper NR (1988) CR2 ligands modulate human B cell activation. J Immunol 141: 2569", "journal-title": "J Immunol"}, {"key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1038/340431a0", "volume": "340", "author": "DP Bolognesi", "year": "1989", "unstructured": "Bolognesi DP (1989) Do antibodies enhance the infection of cells by HIV? Nature 340: 431", "journal-title": "Nature"}, {"key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "1151", "DOI": "10.1084/jem.173.5.1151", "volume": "173", "author": "V Boyer", "year": "1991", "unstructured": "Boyer V, Desgranges C, Trabaud M-A, Fischer E, Kazatchkine MD (1991) Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4\u00af and antibody-independent fashion. J Exp Med 173: 1151", "journal-title": "J Exp Med"}, {"key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1111/j.1365-3083.1992.tb03150.x", "volume": "36", "author": "V Boyer", "year": "1992", "unstructured": "Boyer V, Delibrias C, Noraz N, Fischer E, Kazatchkine MD, Desgranges C (1992) Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scan J Immunol 36: 879", "journal-title": "Scan J Immunol"}, {"key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1353/pbm.1992.0048", "volume": "35", "author": "SB Burke", "year": "1992", "unstructured": "Burke SB (1992) Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk? Perspect Biol Med 35: 511", "journal-title": "Perspect Biol Med"}, {"key": "9_CR15", "first-page": "1755", "volume": "143", "author": "RH Carter", "year": "1989", "unstructured": "Carter RH, Fearon DT (1989) Polymeric C3dg primes human lymphocytes for proliferation induced by anti-IgM. J Immunol 143: 1755", "journal-title": "J Immunol"}, {"key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1126/science.1373518", "volume": "256", "author": "RH Carter", "year": "1992", "unstructured": "Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105", "journal-title": "Science"}, {"key": "9_CR17", "first-page": "457", "volume": "141", "author": "RH Carter", "year": "1988", "unstructured": "Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141: 457", "journal-title": "J Immunol"}, {"key": "9_CR18", "first-page": "3809", "volume": "142", "author": "F Chiodi", "year": "1989", "unstructured": "Chiodi F, Mathiesen T, Albert J, Parks E, Norrby E, Wahren B (1989) IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection. J Immunol 142: 3809", "journal-title": "J Immunol"}, {"key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "954", "DOI": "10.1056/NEJM199104043241404", "volume": "324", "author": "SJ Clark", "year": "1991", "unstructured": "Clark SJ, Saag MS, Decke WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324: 954", "journal-title": "N Engl J Med"}, {"key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1016/0008-8749(89)90037-3", "volume": "121", "author": "JHM Cohen", "year": "1989", "unstructured": "Cohen JHM, Aubry JP, Revillard JP, Banchereau J, Kazatchkine MD (1989) Human T lymphocytes expressing the C3b/C4b complement receptor type one (CR1, CD35) belong to Fc7 receptor-positive CD4-positive T cells. Cell Immunol 121: 383", "journal-title": "Cell Immunol"}, {"key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "9593", "DOI": "10.1073/pnas.88.21.9593", "volume": "88", "author": "RI Connor", "year": "1991", "unstructured": "Connor RI, Dinces NB, Howell AL, Romet-Lemonne J-L, Pasquali J-L, Fanger MW (1991) Fc receptors for IgG (FC7RS) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including FC7R. Proc Natl Acad Sci USA 88: 9593", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1089/aid.1993.9.13", "volume": "9", "author": "MP Cranage", "year": "1993", "unstructured": "Cranage MP, Polyanskaya N, McBride B, Cook N, Ashworth LAE, Dennis M, Baskerville A, Green- away PJ, Corcoran T, Kitchen P, Rose J, Murphey-Corb M, Desrosiers RC, Stott EJ, Farrar GH (1993) Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 9: 13", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1056/NEJM199104043241405", "volume": "324", "author": "ES Daar", "year": "1991", "unstructured": "Daar ES, Moudgil T, Meyer RD, Ho DD (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324: 961", "journal-title": "N Engl J Med"}, {"key": "9_CR24", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1038/312763a0", "volume": "312", "author": "AG Dalgleish", "year": "1984", "unstructured": "Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763", "journal-title": "Nature"}, {"key": "9_CR25", "first-page": "152", "volume": "93", "author": "V Daniel", "year": "1993", "unstructured": "Daniel V, Susal C, Weimer R, Zimmerman R, Huth-Kuhne A, Opelz G (1993) Association of T cell and macrophage dysfunction with surface gpl20-immunoglobulin-complement complexes in HIV- infected patients. Clin Exp Med 93: 152", "journal-title": "Clin Exp Med"}, {"key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "2784", "DOI": "10.1002/eji.1830241131", "volume": "24", "author": "C-C Delibrias", "year": "1994", "unstructured": "Delibrias C-C, Mouhoub A, Fischer E, Kazatchkine MD (1994) CR1 (CD35) and CR2 (CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur J Immunol 24: 2784", "journal-title": "Eur J Immunol"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1126/science.271.5247.348", "volume": "271", "author": "PW Dempsey", "year": "1996", "unstructured": "Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348", "journal-title": "Science"}, {"key": "9_CR28", "first-page": "119", "volume": "114", "author": "R Dolin", "year": "1991", "unstructured": "Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montefiori DC, Stablien DM, Smith GE, Koff WC, the NIAID AIDS Vaccine Clinical Trials Network (1991) The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gpl60 candidate vaccine in humans. Ann Intern Med 114: 119", "journal-title": "The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gpl60 candidate vaccine in humans. Ann Intern Med"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1089/aid.1994.10.13", "volume": "10", "author": "AM Eaton", "year": "1994", "unstructured": "Eaton AM, Ugen KE, Weiner DB, Wildes T, Levy JA (1994) An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. AIDS Res Hum Retroviruses 10: 13", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "1417", "DOI": "10.1084/jem.174.6.1417", "volume": "174", "author": "CF Ebenbichler", "year": "1991", "unstructured": "Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP (1991) Human immunodeficiency virus type 1 activates the classical pathway of complement by direct CI binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 174: 1417", "journal-title": "J Exp Med"}, {"key": "9_CR31", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1016/0167-5699(91)90011-H", "volume": "12", "author": "A Erdie", "year": "1991", "unstructured": "Erdie A, Fust G, Gergely J (1991) The role of C3 in the immune response. Immunol Today 12: 332", "journal-title": "Immunol Today"}, {"key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1016/0167-5699(89)90234-X", "volume": "10", "author": "MW Fanger", "year": "1989", "unstructured": "Fanger MW, Shen L, Graziano RF, Guyre PM (1989) Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 10: 92", "journal-title": "Immunol Today"}, {"key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "1971", "DOI": "10.1073/pnas.75.4.1971", "volume": "75", "author": "DT Fearon", "year": "1978", "unstructured": "Fearon DT (1978) Regulation of membrane sialic acid of BIH-dependent decay dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75: 1971", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1089/vim.1993.6.135", "volume": "6", "author": "SA Fiscus", "year": "1993", "unstructured": "Fiscus SA, Folds JD, Horst CM van der (1993) Infectious immune complexes in HIV-1-infected patients. Viral Immunol 6: 135", "journal-title": "Viral Immunol"}, {"key": "9_CR35", "first-page": "1636", "volume": "137", "author": "LF Fries", "year": "1986", "unstructured": "Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM (1986) Glycoprotein C of Herpes simplex virus type 1 is an inhibitor of the complement cascade. J Immunol 137: 1636", "journal-title": "J Immunol"}, {"key": "9_CR36", "first-page": "11760", "volume": "263", "author": "H Geyer", "year": "1988", "unstructured": "Geyer H, Holschbach C, Hunsman C, Schneider J (1988) Carbohydrates of human immunodefi-ciency virus: structures of oligosaccharides linked to the envelope glycoprotein gpl20. J Biol Chem 263: 11760", "journal-title": "J Biol Chem"}, {"key": "9_CR37", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1056/NEJM199511163332007", "volume": "333", "author": "BS Graham", "year": "1995", "unstructured": "Graham, BS, Wright PF (1995) Candidate AIDS Vaccines. N Engl J Med 333: 1331", "journal-title": "N Engl J Med"}, {"key": "9_CR38", "first-page": "541", "volume": "65", "author": "GS Gras", "year": "1991", "unstructured": "Gras GS, Dormont D,(1991) Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus- transformed B-lymphocytic cell line. J Virol 65:541", "journal-title": "J Virol"}, {"key": "9_CR39", "first-page": "1808", "volume": "81", "author": "G Gras", "year": "1993", "unstructured": "Gras G, Richard Y, Roques P, Olivier R, Dormont D (1993) Complement and virus-specific antibody- dependent infection of normal B lymphocytes by human immunodeficiency virus type 1. Blood 81: 1808", "journal-title": "Blood"}, {"key": "9_CR40", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1038/336070a0", "volume": "336", "author": "D Gray", "year": "1988", "unstructured": "Gray D, Skarvall H (1988) B-cell memory is short-lived in the absence of antigen. Nature 336: 70", "journal-title": "Nature"}, {"key": "9_CR41", "doi-asserted-by": "crossref", "first-page": "2982", "DOI": "10.1002/eji.1830241209", "volume": "24", "author": "I Grosjean", "year": "1994", "unstructured": "Grosjean I, Lachaux A, Bella C, Aubry J-P, Bonnefoy J-V, Kaiserlian D (1994) CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones. Eur J Immunol 24: 2982", "journal-title": "Eur J Immunol"}, {"key": "9_CR42", "first-page": "301", "volume": "31", "author": "SB Halstead", "year": "1982", "unstructured": "Halstead SB (1982) Immune enhancement of viral infection. Prog Allergy 31: 301", "journal-title": "Prog Allergy"}, {"key": "9_CR43", "first-page": "908", "volume": "22", "author": "S Harada", "year": "1985", "unstructured": "Harada S, Yoshiyama H, Yamamoto N (1985) Effect of heat and fresh human serum on the infectivity of human T cell lymphotropic virus type III evaluated with new bioassay systems. J Clin Microbiol 22: 908", "journal-title": "J Clin Microbiol"}, {"key": "9_CR44", "first-page": "1307", "volume": "7", "author": "JS Haurum", "year": "1993", "unstructured": "Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC (1993) Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. J Acquir Immune Defic Syndr 7: 1307", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR45", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1038/377740a0", "volume": "377", "author": "SL Heath", "year": "1995", "unstructured": "Heath SL, Tew JG, Tew JG, Szakal AK, Burton GF (1995) Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377: 740", "journal-title": "Nature"}, {"key": "9_CR46", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1126/science.1718035", "volume": "254", "author": "T Hebell", "year": "1991", "unstructured": "Hebell T, Ahearn JM, Fearon DT (1991) Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254: 102", "journal-title": "Science"}, {"key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1084/jem.172.2.665", "volume": "172", "author": "B Heyman", "year": "1991", "unstructured": "Heyman B, Wiersma EJ, Kinoshita T (1991) In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J Exp Med 172: 665", "journal-title": "J Exp Med"}, {"key": "9_CR48", "first-page": "71", "volume": "46", "author": "RL Hirsch", "year": "1982", "unstructured": "Hirsch RL (1982) The complement system: its importance in the host response to viral infection. Microbiol Rev 46: 71", "journal-title": "Microbiol Rev"}, {"key": "9_CR49", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/BF01315298", "volume": "87", "author": "RL Hirsch", "year": "1986", "unstructured": "Hirsch RL, Wolinsky JS, Winkelstein J A (1986) Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity. Arch Virol 87: 181", "journal-title": "Arch Virol"}, {"key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1038/373123a0", "volume": "373", "author": "DD Ho", "year": "1995", "unstructured": "Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1-infection. Nature 373: 123", "journal-title": "Nature"}, {"key": "9_CR51", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1056/NEJM198809083191004", "volume": "319", "author": "CH Hoke", "year": "1988", "unstructured": "Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S-O, Gingrich JB, Latendresse J, Fukai K, Burke DS (1988) Protection against japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608", "journal-title": "N Engl J Med"}, {"key": "9_CR52", "doi-asserted-by": "crossref", "first-page": "1357", "DOI": "10.1126/science.2786647", "volume": "244", "author": "J Homsy", "year": "1989", "unstructured": "Homsy J, Meyer M, Tateno M, Clarkson S, Levy JA (1989) The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244: 1357", "journal-title": "Science"}, {"key": "9_CR53", "first-page": "1437", "volume": "64", "author": "J Homsy", "year": "1990", "unstructured": "Homsy J, Meyer M, Levy J A (1990) Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol 64: 1437", "journal-title": "J Virol"}, {"key": "9_CR54", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1089/aid.1.1986.2.235", "volume": "2", "author": "Y Inada", "year": "1986", "unstructured": "Inada Y, Lange M, McKinley GF, Sonnabend JA, Fonville TW, Kanemitsu T, Tanaka M, Clark WS (1986) Hematologic correlates and the role of erythrocyte CR1 (C3b receptors) in the development of AIDS. AIDS Res 2: 235", "journal-title": "AIDS Res"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1038/354389a0", "volume": "354", "author": "J Jacob", "year": "1991", "unstructured": "Jacob J, Kelsoe G, Rajewsky K, Weiss U (1991) Intraclonal generation of antibody mutants in germinal centres. Nature 354: 389", "journal-title": "Nature"}, {"key": "9_CR56", "first-page": "1065", "volume": "150", "author": "P Joling", "year": "1993", "unstructured": "Joling P, Bakker LJ, Van Strijp JAG, Meerloo T, Graaf L de, Dekker MEM, Goudsmit J, Verhoef J, Schuurman H-J (1993) Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol 150: 1065", "journal-title": "J Immunol"}, {"key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1097/00002030-198903000-00002", "volume": "3", "author": "T Jouault", "year": "1989", "unstructured": "Jouault T, Chapuis F, Olivier R, Parravicini C, Bahraoui E, Gluckman J-C (1989) HIV infection of monocytic cells: role of antibody-mediated virus binding to Fc7 receptors. AIDS 3: 125", "journal-title": "AIDS"}, {"key": "9_CR58", "first-page": "89", "volume": "1", "author": "M-H Jouvin", "year": "1987", "unstructured": "Jouvin M-H, Rozenbaum W, Russo R, Kazatchkine MD (1987) Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopu- lations of patients with HIV infection. J Acquir Immune Defic Syndr 1: 89", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR59", "first-page": "269", "volume": "5", "author": "RA June", "year": "1991", "unstructured": "June RA, Schade SZ, Bankowski MJ, Kuhns M, McNamara A, Lint TF, Landay AL, Spear GT (1991) Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. J Acquir Immune Defic Syndr 5: 269", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR60", "first-page": "59", "volume": "75", "author": "RA June", "year": "1992", "unstructured": "June RA, Landay AL, Stefanik K, Lint TF, Spear GT (1992) Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons. Immunology 75: 59", "journal-title": "Immunology"}, {"key": "9_CR61", "first-page": "1713", "volume": "10", "author": "MC Keefer", "year": "1994", "unstructured": "Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath J, Clements ML, Gorse GJ, Wright PF, Matthews TJ, Smith GE, Lawrence D, Dolin R, the NIAID AIDS Vaccine Clinical Trials Network (1994) Studies of high doses of a human immunodeficiency virus type 1 (HIV-1) recombinant gpl60 candidate vaccine in HIV-1 seronegative humans. AIDS Res Hum Retroviruses 10: 1713", "journal-title": "Studies of high doses of a human immunodeficiency virus type 1 (HIV-1) recombinant gpl60 candidate vaccine in HIV-1 seronegative humans. AIDS Res Hum Retroviruses"}, {"key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1089/aid.1988.4.3", "volume": "4", "author": "J Khalife", "year": "1988", "unstructured": "Khalife J, Guy B, Capron M, Kieny M-P, Ameisen J-C, Montagnier L, Lecocq J-P, Capron A (1988) Isotypic restriction of antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses 4: 3", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR63", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1016/0167-5699(91)90001-A", "volume": "12", "author": "T Kinoshita", "year": "1991", "unstructured": "Kinoshita T (1991) Biology of complement: the overture. Immunol Today 12: 291", "journal-title": "Immunol Today"}, {"key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "1026", "DOI": "10.1093/infdis/156.6.1026", "volume": "156", "author": "PJ Klasse", "year": "1987", "unstructured": "Klasse PJ, Blomberg J (1987) Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG. J Infect Dis 156: 1026", "journal-title": "J Infect Dis"}, {"key": "9_CR65", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1111/j.1600-065X.1980.tb01038.x", "volume": "53", "author": "GGB Klaus", "year": "1980", "unstructured": "Klaus GGB, Humphrey JH, Kunkle A, Dongworth DW (1980) The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev 53: 3", "journal-title": "Immunol Rev"}, {"key": "9_CR66", "doi-asserted-by": "crossref", "first-page": "11518", "DOI": "10.1073/pnas.90.24.11518", "volume": "90", "author": "SC Kliks", "year": "1993", "unstructured": "Kliks SC, Shioda T, Haigwood NL, Levy JA (1993) V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90: 11518", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR67", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1093/infdis/168.3.729", "volume": "168", "author": "K Kobayashi", "year": "1993", "unstructured": "Kobayashi K, Takeda A, Green S, Tuazon CU, Ennis FA (1993) Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons. J Infect Dis 168: 729", "journal-title": "J Infect Dis"}, {"key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1146/annurev.bi.54.070185.003215", "volume": "54", "author": "R Kornfeld", "year": "1985", "unstructured": "Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54: 631", "journal-title": "Annu Rev Biochem"}, {"key": "9_CR69", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1126/science.2237434", "volume": "250", "author": "GJ Kotwal", "year": "1990", "unstructured": "Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827", "journal-title": "Science"}, {"key": "9_CR70", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1126/science.3629244", "volume": "237", "author": "M Kowalski", "year": "1987", "unstructured": "Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, Sodroski J (1987) Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237: 1351", "journal-title": "Science"}, {"key": "9_CR71", "first-page": "6163", "volume": "154", "author": "PA Kozlowski", "year": "1995", "unstructured": "Kozlowski PA, Black KP, Shen L, Jackson S (1995) High prevalence of serum IgA HIV-1-infection- enhancing antibodies in HIV-infected persons. J Immunol 154: 6163", "journal-title": "J Immunol"}, {"key": "9_CR72", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1016/0167-5699(91)90005-E", "volume": "12", "author": "PJ Lachman", "year": "1991", "unstructured": "Lachman PJ (1991) The control of homologous lysis. Immunol Today 12: 312", "journal-title": "Immunol Today"}, {"key": "9_CR73", "doi-asserted-by": "crossref", "first-page": "1641", "DOI": "10.1089/aid.1992.8.1641", "volume": "8", "author": "AJ Langlois", "year": "1992", "unstructured": "Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP (1992) Detection of anti- human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 8: 1641", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR74", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1016/0092-8674(87)90524-1", "volume": "50", "author": "LA Lasky", "year": "1987", "unstructured": "Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ (1987) Delineation of a region of the human immunodeficiency virus gpl20 glycoprotein critical for interaction with the CD4 receptor. Cell 50: 975", "journal-title": "Cell"}, {"key": "9_CR75", "first-page": "338", "volume": "70", "author": "J Laurence", "year": "1990", "unstructured": "Laurence J, Saunders A, Early E, Salmon JE (1990) Human immunodeficiency virus infection of monocytes: relationship to Fc\u03b3 receptors and antibody-dependent viral enhancement. Immunol 70: 338", "journal-title": "Immunol"}, {"key": "9_CR76", "doi-asserted-by": "crossref", "first-page": "4205", "DOI": "10.1073/pnas.86.11.4205", "volume": "86", "author": "MM Lederman", "year": "1989", "unstructured": "Lederman MM, Purvis SF, Walter EI, Carey JT, Medof ME (1989) Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay- acelerating factor. Proc Natl Acad Sci USA 86: 4205", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR77", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/0167-5699(92)90199-H", "volume": "13", "author": "Y-J Liu", "year": "1992", "unstructured": "Liu Y-J, Johnson GD, Gordon J, MacLennan ICM (1992) Germinal centres in T cell-dependent antibody responses. Immunol Today 13: 17", "journal-title": "Immunol Today"}, {"key": "9_CR78", "first-page": "4448", "volume": "153", "author": "AT Luxembourg", "year": "1994", "unstructured": "Luxembourg AT, Cooper NR (1994) Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J Immunol 153: 4448", "journal-title": "J Immunol"}, {"key": "9_CR79", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1093/infdis/166.1.93", "volume": "166", "author": "A Mabondzo", "year": "1992", "unstructured": "Mabondzo A, Aussage P, Bartholeyns J, Le Naour R, Raoul H, Romet-Lemonne J-L, Dormont D (1992) Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1-infection. J Infect Dis 166:93", "journal-title": "J Infect Dis"}, {"key": "9_CR80", "first-page": "617", "volume": "7", "author": "DL Mann", "year": "1994", "unstructured": "Mann DL, Hamlin-Green G, Willoughby A, Landesman SH, Goedert, JJ (1994) Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission. J Acquir Immune Defic Syndr 7: 617", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR81", "first-page": "903", "volume": "7", "author": "P Marschang", "year": "1993", "unstructured": "Marschang P, Gurtler L, Totsch M, Thielens NM, Arlaud GJ, Hittmair A, Katinger H, Dierich MP (1993) HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells. J Acquir Immune Defic Syndr 7: 903", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR82", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1002/eji.1830250147", "volume": "25", "author": "P Marschang", "year": "1995", "unstructured": "Marschang P, Sodroski J, Wurzner R, Dierich MP (1995) Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol 25: 285", "journal-title": "Eur J Immunol"}, {"key": "9_CR83", "first-page": "3720", "volume": "138", "author": "O Martinez-Maza", "year": "1987", "unstructured": "Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV (1987) Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 138: 3720", "journal-title": "J Immunol"}, {"key": "9_CR84", "doi-asserted-by": "crossref", "first-page": "1175", "DOI": "10.1089/aid.1993.9.1175", "volume": "9", "author": "JR Mascola", "year": "1993", "unstructured": "Mascola JR, Matthieson BJ, Zack PM, Walker MC, Halstead SB, Burke DS (1993) Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses 9: 1175", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR85", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1084/jem.173.1.55", "volume": "173", "author": "AK Matsumoto", "year": "1991", "unstructured": "Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte- containing complement receptor type 2 and CD19. J Exp Med 173: 55", "journal-title": "J Exp Med"}, {"key": "9_CR86", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1002/j.1460-2075.1988.tb02839.x", "volume": "7", "author": "MO McClure", "year": "1987", "unstructured": "McClure MO, Marsh M, Weiss RA (1987) Human immunodeficiency virus type 1 infection of CD4- bearing cells occurs by a pH-independent mechanism. EMBO J 7: 513", "journal-title": "EMBO J"}, {"key": "9_CR87", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1093/infdis/158.5.1088", "volume": "158", "author": "TM McHugh", "year": "1988", "unstructured": "McHugh TM, Stites DP, Busch MP, Krowka JF, Strieker RB, Hollander H (1988) Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients. J Infect Dis 158: 1088", "journal-title": "J Infect Dis"}, {"key": "9_CR88", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1016/0042-6822(81)90230-0", "volume": "114", "author": "JJ McSharry", "year": "1981", "unstructured": "McSharry JJ, Pickering RJ, Caliguiri LA (1981) Activation of the alternate complement pathway by enveloped viruses containing limited amounts of sialic acid. Virology 114: 507", "journal-title": "Virology"}, {"key": "9_CR89", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1038/317264a0", "volume": "317", "author": "F Melchers", "year": "1985", "unstructured": "Melchers F, Erdei A, Schultz T, Dierich MP (1985) Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317: 264", "journal-title": "Nature"}, {"key": "9_CR90", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1042/bj2540599", "volume": "254", "author": "T Mizouchi", "year": "1988", "unstructured": "Mizouchi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T (1988) Carbohydrate structures of the human immunodeficiency virus (HIV) recombinant envelope glycoprotein gpl20 produced in Chinese hamster ovary cells. Biochem J 254: 599", "journal-title": "Biochem J"}, {"key": "9_CR91", "doi-asserted-by": "crossref", "first-page": "1429", "DOI": "10.1089/aid.1995.11.1429", "volume": "11", "author": "DC Montefiori", "year": "1995", "unstructured": "Montefiori DC (1995) New insights into the role of host ceil proteins in antiviral vaccine protection. AIDS Res Hum Retroviruses 11: 1429", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR92", "author": "DC Montefiori", "first-page": "31", "year": "1996", "unstructured": "Montefiori DC (1996) Role of complement in HIV and SIV pathogenesis and immunity. In: Eible MM, Huber C, Peter HH, Wahn U (eds) Symposium in Immunology. V Antiviral Immunity. Springer, Heidelberg Berlin New York, pp 31 - 53", "volume-title": "Eible MM"}, {"key": "9_CR93", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/0166-3542(89)90025-9", "volume": "11", "author": "DC Montefiori", "year": "1989", "unstructured": "Montefiori DC, Robinson WE, Mitchell WM (1989) Antibody-independent, complement-mediated enhancement of HIV-1-infection by mannosidase I and II inhibitors. Antiviral Res 11: 137", "journal-title": "Antiviral Res"}, {"key": "9_CR94", "first-page": "113", "volume": "64", "author": "DC Montefiori", "year": "1990", "unstructured": "Montefiori DC, Robinson WE Jr, Hirsch VM, Modliszewski A, Mitchell WM, Johnson PR (1990) Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus monkeys. J Virol 64: 113", "journal-title": "J Virol"}, {"key": "9_CR95", "first-page": "513", "volume": "5", "author": "Montefiori DC, Lefkowitz LB, Keller RE, Holmberg V, Sandstrom E, Phair JP, the Multicenter AIDS Cohort Study Group", "year": "1991", "unstructured": "Montefiori DC, Lefkowitz LB, Keller RE, Holmberg V, Sandstrom E, Phair JP, the Multicenter AIDS Cohort Study Group (1991) Absence of a clinical correlation for complement-mediated, infection- enhancing antibodies in plasma and sera from HIV-1 infected persons. J Acquir Immune Defic Syndr 5: 513", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR96", "first-page": "429", "volume": "12", "author": "DC Montefiori", "year": "1992", "unstructured": "Montefiori DC, Graham BS, Kliks S, Wright PF, the NIAID AIDS Vaccine Clinical Trials Nework (1992) Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gpl60. J Clin Immunol 12: 429", "journal-title": "Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gpl60. J Clin Immunol"}, {"key": "9_CR97", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1111/j.1365-2249.1992.tb05855.x", "volume": "90", "author": "DC Montefiori", "year": "1992", "unstructured": "Montefiori DC, Zhou J, Shaff DI (1992) CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody. Clin Exp Immunol 90: 383", "journal-title": "Clin Exp Immunol"}, {"key": "9_CR98", "first-page": "2699", "volume": "67", "author": "DC Montefiori", "year": "1993", "unstructured": "Montefiori DC, Stewart K, Ahearn JM, Zhou JT, Zhou JY (1993) Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J Virol 67: 2699", "journal-title": "J Virol"}, {"key": "9_CR99", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1006/viro.1994.1622", "volume": "205", "author": "DC Montefiori", "year": "1994", "unstructured": "Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR (1994) Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205: 82", "journal-title": "Virology"}, {"key": "9_CR100", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1093/infdis/170.2.429", "volume": "170", "author": "DC Montefiori", "year": "1994", "unstructured": "Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM (1994) Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor, CR1 (CD35), and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 170: 429", "journal-title": "J Infect Dis"}, {"key": "9_CR101", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.1089/aid.1995.11.963", "volume": "11", "author": "DC Montefiori", "year": "1995", "unstructured": "Montefiori DC, Reimann KA, Letvin NL, Zhou J, Hu S-L (1995) Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. AIDS Res Hum Retroviruses 11:963", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR102", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1093/infdis/173.1.60", "volume": "173", "author": "DC Montefiori", "year": "1996", "unstructured": "Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS (1996) Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 173: 60", "journal-title": "J Infect Dis"}, {"key": "9_CR103", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/0090-1229(86)90196-0", "volume": "40", "author": "WJW Morrow", "year": "1986", "unstructured": "Morrow WJW, Wharton M, Strieker RB, Levy J A (1986) Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol 40: 515", "journal-title": "Clin Immunol Immunopathol"}, {"key": "9_CR104", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1146/annurev.bi.57.070188.001541", "volume": "57", "author": "H Muller-Eberhard", "year": "1988", "unstructured": "Muller-Eberhard H (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57: 321", "journal-title": "Annu Rev Biochem"}, {"key": "9_CR105", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1111/j.1365-3083.1994.tb03371.x", "volume": "39", "author": "EB Nikolova", "year": "1994", "unstructured": "Nikolova EB, Tomana M, Russell MW (1994) All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or antigen alone. Scand J Immunol 39: 275", "journal-title": "Scand J Immunol"}, {"key": "9_CR106", "first-page": "321", "volume": "82", "author": "EB Nikolova", "year": "1994", "unstructured": "Nikolova EB, Tomana M, Russell MW (1994) The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human complement. Immunology 82: 321", "journal-title": "Immunology"}, {"key": "9_CR107", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1093/infdis/162.1.21", "volume": "162", "author": "P Nishanian", "year": "1990", "unstructured": "Nishanian P, Huskins KR, Stehn S, Detels R, Fahey JL (1990) A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis 162:21", "journal-title": "J Infect Dis"}, {"key": "9_CR108", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1146/annurev.iy.13.040195.002415", "volume": "13", "author": "G Pantaleo", "year": "1995", "unstructured": "Pantaleo G, Fauci AS (1995) New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 13: 487", "journal-title": "Annu Rev Immunol"}, {"key": "9_CR109", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1111/j.1600-065X.1994.tb00867.x", "volume": "140", "author": "G Pantaleo", "year": "1994", "unstructured": "Pantaleo G, Graziosi C, Demarest JF, Cohen OJ, Vaccarezza, Gantt K, Muro-Cacho C, Fauci AS (1994) Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 140: 105", "journal-title": "Immunol Rev"}, {"key": "9_CR110", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.7326/0003-4819-101-4-429", "volume": "101", "author": "V Pardo", "year": "1984", "unstructured": "Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Burgoignie J (1984) Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101: 429", "journal-title": "Ann Intern Med"}, {"key": "9_CR111", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1126/science.271.5255.1582", "volume": "271", "author": "AS Perelson", "year": "1996", "unstructured": "Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582", "journal-title": "Science"}, {"key": "9_CR112", "doi-asserted-by": "crossref", "first-page": "1043", "DOI": "10.1084/jem.171.4.1043", "volume": "171", "author": "C-F Perno", "year": "1990", "unstructured": "Perno C-F, Baseler MW, Broder S, Yarchoan R (1990) Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gpl20 binding, even in the presence of enhancing antibodies. J Exp Med 171: 1043", "journal-title": "J Exp Med"}, {"key": "9_CR113", "first-page": "500", "volume": "70", "author": "R Perricone", "year": "1987", "unstructured": "Perricone R, Fontana L, De Carolis C, Carini C, Sirianni MC, Aiuti F (1987) Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphadenopathy syndrome (LAS). Clin Exp Immunol 70: 500", "journal-title": "Clin Exp Immunol"}, {"key": "9_CR114", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1089/aid.1995.11.577", "volume": "11", "author": "C Pinter", "year": "1995", "unstructured": "Pinter C, Siccardi AG, Longhi R, Clivio A (1995) Direct interaction of complement factor H with the CI domain of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses 11: 577", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR115", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/S0065-3527(08)60268-7", "volume": "31", "author": "JS Porterfield", "year": "1986", "unstructured": "Porterfield JS (1986) Antibody-dependent enhancement of viral infectivity. Adv Virus Res 31: 335", "journal-title": "Adv Virus Res"}, {"key": "9_CR116", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1146/annurev.bi.57.070188.004033", "volume": "57", "author": "TW Rademacher", "year": "1988", "unstructured": "Rademacher TW, Parekh RB, Dwek RA (1988) Glycobiology. Annu Rev Biochem 57: 785", "journal-title": "Glycobiology. Annu Rev Biochem"}, {"key": "9_CR117", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1146/annurev.iy.09.040191.002325", "volume": "9", "author": "JV Ravetch", "year": "1991", "unstructured": "Ravetch JV, Kinet J-P (1991) Fc receptors. Annu Rev Immunol 9: 457", "journal-title": "Fc receptors. Annu Rev Immunol"}, {"key": "9_CR118", "first-page": "961", "volume": "4", "author": "EC Reisinger", "year": "1990", "unstructured": "Reisinger EC, Vogetseder W, Berzow D, Kofler D, Bitterlich G, Lehr HA, Wachter H, Dierich MP (1990) Complement-mediated enhancement of HIV-1-infection of the monoblastoid cell line U937. J Acquir Immune Defic Syndr 4: 961", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR119", "first-page": "2687", "volume": "135", "author": "M Reynes", "year": "1985", "unstructured": "Reynes M, Aubert JP, Cohen JHM, Audouin J, Tricottet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135: 2687", "journal-title": "J Immunol"}, {"key": "9_CR120", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1016/S0140-6736(88)91657-1", "volume": "1", "author": "WE Robinson", "year": "1988", "unstructured": "Robinson WE, Montefiori DC, Mitchell WM (1988) Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1: 790", "journal-title": "Lancet"}, {"key": "9_CR121", "first-page": "33", "volume": "2", "author": "WE Robinson", "year": "1989", "unstructured": "Robinson WE, Montefiori DC, Gillespie DH, Mitchell WM (1989) Complement-mediated, antibody- dependent enhancement of HIV-1-infection in vitro is characterized by increased protein and RNA synthesis and infectious virus release. J Acquir Immune Defic Syndr 2: 33", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR122", "first-page": "5301", "volume": "64", "author": "WE Robinson", "year": "1990", "unstructured": "Robinson WE, Kawamura T, Lake D, Masuho Y, Mitchell WM, Hersh EM (1990) Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1-infection in vitro. J Virol 64: 5301", "journal-title": "J Virol"}, {"key": "9_CR123", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1016/0042-6822(90)90449-2", "volume": "175", "author": "WE Robinson", "year": "1990", "unstructured": "Robinson WE, Montefiori DC, Mitchell WM (1990) Complement-mediated antibody-dependent en-hancement of HIV-1 infection requires CD4 and complement receptors. Virology 175: 600", "journal-title": "Virology"}, {"key": "9_CR124", "first-page": "4169", "volume": "65", "author": "WE Robinson", "year": "1991", "unstructured": "Robinson WE, Gorny MW, Xu J-Y, Mitchell WM, Zolla-Pazner S (1991) Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 65: 4169", "journal-title": "J Virol"}, {"key": "9_CR125", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0065-2776(08)60341-7", "volume": "37", "author": "GD Ross", "year": "1985", "unstructured": "Ross GD, Medof E (1985) Membrane complement receptors specific for bound fragments of C3. Adv Immunol 37: 217", "journal-title": "Adv Immunol"}, {"key": "9_CR126", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1056/NEJM198709103171110", "volume": "317", "author": "WF Rosse", "year": "1987", "unstructured": "Rosse WF (1987) The spleen as a filter. N Engl J Med 317: 704", "journal-title": "N Engl J Med"}, {"key": "9_CR127", "first-page": "730", "volume": "68", "author": "RP Rother", "year": "1994", "unstructured": "Rother RP, Rollins SA, Fodor WL, Albrecht J-C, Setter E, Fleckenstein B, Squinto SP (1994) Inhibi-tion of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68: 730", "journal-title": "J Virol"}, {"key": "9_CR128", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1111/j.1365-3083.1989.tb01199.x", "volume": "30", "author": "MW Russell", "year": "1989", "unstructured": "Russell MW, Mansa B (1989) Complement-fixing properties of human IgA antibodies. Scand J Immunol 30: 175", "journal-title": "Scand J Immunol"}, {"key": "9_CR129", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1084/jem.182.2.501", "volume": "182", "author": "M Saifuddin", "year": "1995", "unstructured": "Saifuddin M, Parker CJ, Peeples ME, Gorny MK, Zolla-Pazner S, Ghassemi M, Rooney IA, Atkinson JP, Spear GT (1995) Role of virion-associated giycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 182: 501", "journal-title": "J Exp Med"}, {"key": "9_CR130", "first-page": "899", "volume": "141", "author": "JA Schifferli", "year": "1988", "unstructured": "Schifferli JA, Ng YC, Estreicher J, Walport MJ (1988) The clearance of tetanus toxoid-anti-tetanus toxoid immune complexes from the circulation of humans: complement- and erythrocyte CR1- dependent mechanisms. J Immunol 141: 899", "journal-title": "J Immunol"}, {"key": "9_CR131", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1007/978-1-4615-2492-2_28", "volume": "355", "author": "J Schmitz", "year": "1994", "unstructured": "Schmitz J, Lunzen J van, Tenner-Racz K, Grosschupff G, Racz P, Schmitz H, Dietrich M, Hufert F (1994) Follicular dendritic cells (FDC) are not productively infected with HIV-1 in vivo. Adv Exp Med Biol 355: 165", "journal-title": "Adv Exp Med Biol"}, {"key": "9_CR132", "doi-asserted-by": "crossref", "first-page": "1520", "DOI": "10.1172/JCI118190", "volume": "95", "author": "J Schmitz", "year": "1995", "unstructured": "Schmitz J, Zimmer JP, Kluxen B, Aries S, Bogel M, Gigli I, Schmitz H (1995) Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1-infection is controlled by CD55 and CD59. J Clin Invest 95: 1520", "journal-title": "J Clin Invest"}, {"key": "9_CR133", "doi-asserted-by": "crossref", "first-page": "5175", "DOI": "10.1021/bi00668a035", "volume": "15", "author": "V Schumaker", "year": "1976", "unstructured": "Schumaker V, Calcott M, Spiegelberg H, Muller-Eberhard H (1976) Ultracentrifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement. Biochemistry 15: 5175", "journal-title": "Biochemistry"}, {"key": "9_CR134", "first-page": "421", "volume": "7", "author": "J Schupbach", "year": "1994", "unstructured": "Schupbach J, Tomasik Z, Jendis J, Boni J, Seger R, Kind C (1994) IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. J AIDS 7: 421", "journal-title": "J AIDS"}, {"key": "9_CR135", "first-page": "37", "volume": "7", "author": "ME Scott", "year": "1993", "unstructured": "Scott, ME, Landay AL, Lint TF, Spear GT (1993) In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. J Acquir Immune Defic Syndr 7: 37", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR136", "doi-asserted-by": "crossref", "first-page": "1227", "DOI": "10.1093/infdis/162.6.1227", "volume": "162", "author": "G Senaldi", "year": "1990", "unstructured": "Senaldi G, Peakman M, McManus T, Davies ET, Tee DEH, Vergani D (1990) Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 162: 1227", "journal-title": "J Infect Dis"}, {"key": "9_CR137", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/S0163-4453(95)92185-0", "volume": "31", "author": "G Senaldi", "year": "1995", "unstructured": "Senaldi G., Davies ET, Mahalingham M, Lu J, Pozniak A, Peakman M, Reid KBM, Vergani D (1995) Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect 31: 145", "journal-title": "J Infect"}, {"key": "9_CR138", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1038/bjc.1992.384", "volume": "66", "author": "D Serraino", "year": "1992", "unstructured": "Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB, Ancelle-Park RA (1992) The epidemiology of AIDS-associated non-Hodgkin\u2019s lymphoma in the World Health Organization European Region. Br J Cancer 66: 912", "journal-title": "Br J Cancer"}, {"key": "9_CR139", "first-page": "4309", "volume": "65", "author": "PP Shadduck", "year": "1991", "unstructured": "Shadduck PP, Weinberg JB, Haney AF, Bartlett JA, Langlois AJ, Bolognesi DP, Matthews TJ (1991) Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1-infection of human blood monocytes and peritoneal macrophages. J Virol 65: 4309", "journal-title": "J Virol"}, {"key": "9_CR140", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1172/JCI115621", "volume": "89", "author": "A Shirai", "year": "1992", "unstructured": "Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM (1992) Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 89: 561", "journal-title": "J Clin Invest"}, {"key": "9_CR141", "first-page": "3704", "volume": "69", "author": "KHJ Siebelink", "year": "1995", "unstructured": "Siebelink KHJ, Tyhaar E, Huisman RC, Huisman W, Ronde A de, Darby IH, Francis MJ, Rim-melzwaan GF, Osterhaus ADME (1995) Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol 69: 3704", "journal-title": "J Virol"}, {"key": "9_CR142", "first-page": "857", "volume": "55", "author": "ML Smiley", "year": "1985", "unstructured": "Smiley ML, Friedman HM (1985) Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. J Virol 55: 857", "journal-title": "J Virol"}, {"key": "9_CR143", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/0165-2478(89)90180-6", "volume": "22", "author": "BM Soelder", "year": "1989", "unstructured": "Soelder BM, Schultz TF, Hengster P, Lower J, Larcher C, Bitterlich G, Kurth R, Wachter H, Dierich MP (1989) HIV and HIV-infected cells differentially activate the human complement system independently of antibody. Immunol Lett 22: 135", "journal-title": "Immunol Lett"}, {"key": "9_CR144", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/S0140-6736(89)90452-2", "volume": "11", "author": "BM Soelder", "year": "1989", "unstructured": "Soelder BM, Reisinger EC, Koefler D, Bitterlich G, Wachter H, Dierich MP (1989) Complement receptors: another port of entry for HIV. Lancet 11: 271", "journal-title": "Lancet"}, {"key": "9_CR145", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1089/aid.1991.7.579", "volume": "7", "author": "GT Spear", "year": "1991", "unstructured": "Spear GT, Jiang H, Sullivan BL, Gewurz H, Landay AL, Lint TF (1991) Direct binding of complement component Clq to human immunodeficiency virus (HIV) and human T lymphoptropic virus-I (HTLV- I) coinfected cells. AIDS Res Hum Retroviruses 7: 579", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR146", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1006/viro.1993.1398", "volume": "195", "author": "GT Spear", "year": "1993", "unstructured": "Spear GT, Takefman DM, Sullivan BL, Landay AL, Jennings MB, Carlson JR (1993) Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology 195: 475", "journal-title": "Virology"}, {"key": "9_CR147", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/S0065-2776(08)60254-0", "volume": "19", "author": "HL Spiegelberg", "year": "1974", "unstructured": "Spiegelberg HL (1974) Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 19: 259", "journal-title": "Adv Immunol"}, {"key": "9_CR148", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1016/0092-8674(86)90778-6", "volume": "45", "author": "BR Starcich", "year": "1986", "unstructured": "Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, Wong-Staal F (1986) Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45: 637", "journal-title": "Cell"}, {"key": "9_CR149", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1016/0092-8674(87)90542-3", "volume": "49", "author": "BS Stein", "year": "1987", "unstructured": "Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, Engleman EG (1987) pH-independent HIV entry into CD4-positive cells via virus envelope fusion to the plasma membrane. Cell 49:659", "journal-title": "Cell"}, {"key": "9_CR150", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1084/jem.183.1.307", "volume": "183", "author": "H Stoiber", "year": "1996", "unstructured": "Stoiber H, Pinter C, Siccardi AG, Clivio, A, Dierich MP (1996) Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 183: 307", "journal-title": "J Exp Med"}, {"key": "9_CR151", "first-page": "1327", "volume": "134", "author": "T Suga", "year": "1985", "unstructured": "Suga T, Endoh M, Sakai H, Miura M, Tomino Y, Nomoto Y (1985) T-alpha cell subsets in human peripheral blood. 1989. J Immunol 134: 1327", "journal-title": "J Immunol"}, {"key": "9_CR152", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1093/infdis/153.5.970", "volume": "153", "author": "V-A Sundquist", "year": "1986", "unstructured": "Sundquist V-A, Linde A, Kurth R, Werner A, Helm EB, Popovic M, Gallo RC, Wahren B (1986) Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis 153: 970", "journal-title": "J Infect Dis"}, {"key": "9_CR153", "first-page": "6028", "volume": "152", "author": "C Susal", "year": "1994", "unstructured": "Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G (1994) Complement activation by recombinant HIV-1 glycoprotein gpl20. J Immunol 152: 6028", "journal-title": "J Immunol"}, {"key": "9_CR154", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1126/science.2972065", "volume": "242", "author": "A Takeda", "year": "1988", "unstructured": "Takeda A, Tuazon CU, Ennis FA (1988) Antibody-enhanced infection by HIV-1 via Fc receptor- mediated entry. Science 242: 580", "journal-title": "Science"}, {"key": "9_CR155", "first-page": "5605", "volume": "64", "author": "A Takeda", "year": "1990", "unstructured": "Takeda A, Sweet RW, Ennis FA (1990) Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and FC7R. \u2019J Virol 64: 5605", "journal-title": "Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and FC7R. \u2019J Virol"}, {"key": "9_CR156", "doi-asserted-by": "crossref", "first-page": "977", "DOI": "10.1172/JCI112688", "volume": "78", "author": "FA Tausk", "year": "1986", "unstructured": "Tausk FA, McCutchan JA, Spechko P, Schreiber RD, Gigli I (1986) Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 78: 977", "journal-title": "J Clin Invest"}, {"key": "9_CR157", "first-page": "678", "volume": "133", "author": "TF Tedder", "year": "1984", "unstructured": "Tedder TF, Clement LY, Cooper MD (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133: 678", "journal-title": "J Immunol"}, {"key": "9_CR158", "first-page": "1063", "volume": "120", "author": "JG Tew", "year": "1978", "unstructured": "Tew JG, Mandel TE (1978) The maintenance and regulation of serum antibody levels: evidence indicating a role for antigen retained in lymphoid follicles. J Immunol 120: 1063", "journal-title": "J Immunol"}, {"key": "9_CR159", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/0162-3109(92)90015-5", "volume": "24", "author": "S Theil", "year": "1992", "unstructured": "Theil S (1992) Mannan-binding protein, a complement activating animal lectin. Immunopharmacology 24: 91", "journal-title": "Immunopharmacology"}, {"key": "9_CR160", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1084/jem.65.6.787", "volume": "65", "author": "M Theiler", "year": "1937", "unstructured": "Theiler M, Smith HH (1937) The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65: 787", "journal-title": "J Exp Med"}, {"key": "9_CR161", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1111/j.1365-2249.1993.tb05955.x", "volume": "92", "author": "N Thieblemont", "year": "1993", "unstructured": "Thieblemont N, Haeffner-Cavaillon N, Ledur A, L\u2019age-Stehr J, Ziegler-Heitbrock HWL, Kazatchkine MD (1993) CR1 (CD35) and CR3 (CDllb/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin Exp Immunol 92: 106", "journal-title": "Clin Exp Immunol"}, {"key": "9_CR162", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1089/aid.1993.9.229", "volume": "9", "author": "N Thieblemont", "year": "1993", "unstructured": "Thieblemont N, Haeffner-Cavaillon N, Weiss L, Maillet F, Kazatchkine MD (1993) Complement activation by gpl60 glycoprotein of HIV-1. AIDS Res Hum Retroviruses 9: 229", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR163", "first-page": "6583", "volume": "151", "author": "NM Thielens", "year": "1993", "unstructured": "Thielens NM, Bally IM, Ebenbichler CF, Dierich, MP, Arlaud GJ (1993) Further characterization of the interaction between the Clq subcomponent of human CI and the transmembrane envelope glycoprotein gp41 of HIV-1. J Immunol 151: 6583", "journal-title": "J Immunol"}, {"key": "9_CR164", "first-page": "224", "volume": "147", "author": "G Thyphronitis", "year": "1991", "unstructured": "Thyphronitis G, Kinoshita T, Inoue K, Schweinle JE, Tsokos GC, Mecalf ES, Finkelman FD, Balow JE (1991) Modulation of mouse complement receptors 1 and 2 suppresses antibody response in vivo. J Immunol 147: 224", "journal-title": "J Immunol"}, {"key": "9_CR165", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1111/j.1365-2249.1994.tb06040.x", "volume": "96", "author": "FD Toth", "year": "1994", "unstructured": "Toth FD, Mosborg-Petersen P, Kiss J, Aboagye-Mathiesen G, Zdravkovic M, Hager H, Aranyosi J, Lampe L, Ebbesen P (1994) Antibody-dependent enhancement of HIV-1-infection in human term syncytiotrophoblast cells cultured in vitro. Clin Exp Immunol 96: 389", "journal-title": "Clin Exp Immunol"}, {"key": "9_CR166", "doi-asserted-by": "crossref", "first-page": "1791", "DOI": "10.1084/jem.171.5.1791", "volume": "171", "author": "M Tremblay", "year": "1990", "unstructured": "Tremblay M, Meloche S, Sekaly RP, Wainberg MA (1990) Complement receptor type 2 mediates enhancement of human immunodeficiency virus type 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med 171: 1791", "journal-title": "J Exp Med"}, {"key": "9_CR167", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1089/aid.1995.11.343", "volume": "11", "author": "H Trischmann", "year": "1995", "unstructured": "Trischmann H, Davis D, Lachmann PJ (1995) Lymphocytic strains of HIV-1 when complexed with enhancing antibodies can infect macrophages via FC7RIII. independently of CD4. AIDS Res Hum Retroviruses 11: 343", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "9_CR168", "first-page": "1640", "volume": "144", "author": "GC Tsokos", "year": "1990", "unstructured": "Tsokos GC, Lambris JD, Finkelman FD, Anastassiou ED, June CH (1990) Monovalent ligands of complement receptor 2 inhibit, whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic-free calcium concentration. J Immunol 144: 1640", "journal-title": "J Immunol"}, {"key": "9_CR169", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.1126/science.2994223", "volume": "229", "author": "FM Veronese", "year": "1985", "unstructured": "Veronese FM, DeVico AL, Copeland TD, Droszland S, Gallo RC, Sarngadharan MG (1985) Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229: 1402", "journal-title": "Science"}, {"key": "9_CR170", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1006/viro.1994.1120", "volume": "199", "author": "SZS Wang", "year": "1994", "unstructured": "Wang S Z-S, Rushlow KE, Issel CJ, Cook RF, Cook SJ, Raabe ML, Chong Y-H, Costa L, Monte-laro RC (1994) Enhancement of EIAV replication and disease by immunization with a baculovirus- expressed recombinant envelope surface glycoprotein. Virology 199: 247", "journal-title": "Virology"}, {"key": "9_CR171", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1038/373117a0", "volume": "373", "author": "X Wei", "year": "1995", "unstructured": "Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson, JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117", "journal-title": "Nature"}, {"key": "9_CR172", "first-page": "379", "volume": "6", "author": "L Weiss", "year": "1992", "unstructured": "Weiss L, Okada N, Haeffner-Cavaillon N, Hattori C, Faucher C, Kazatchkine MD, Okada H (1992) Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T- lymphocytes of HIV-infected patients. J Acquir Immune Defic Syndr 6: 379", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR173", "first-page": "824", "volume": "66", "author": "BS Wilson", "year": "1985", "unstructured": "Wilson BS, Piatt JL, Kay NE (1985) Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood 66: 824", "journal-title": "Blood"}, {"key": "9_CR174", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1093/intimm/8.1.153", "volume": "8", "author": "XS Wu", "year": "1996", "unstructured": "Wu XS, Okada N, Iwamori M, Okada H (1996) IgM natural antibody against an asialo-oligosaccharide, gangliotetraose (GG4), sensitizes HIV-1-infected cells for cytolysis by homologous complement. Int Immunol 8: 153", "journal-title": "Int Immunol"}, {"key": "9_CR175", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1093/intimm/3.4.395", "volume": "3", "author": "E Yefenof", "year": "1991", "unstructured": "Yefenof E, Asjo B, Klein E (1991) Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity. Int Immunol 3: 395", "journal-title": "Int Immunol"}, {"key": "9_CR176", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1089/aid.1990.6.629", "volume": "6", "author": "M Zeira", "year": "1990", "unstructured": "Zeira M, Byrn RA, Groopman JE (1990) Inhibition of serum-enhanced HIV-1-infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody. AIDS Res Hum Retroviruses 6: 629", "journal-title": "AIDS Res Hum Retroviruses"}], "container-title": ["Immunopathogenesis of HIV Infection"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-60867-4_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T19:32:51Z", "timestamp": 1554147171000}, "score": 27.077412, "issued": {"date-parts": [[1997]]}, "ISBN": ["9783642645938", "9783642608674"], "references-count": 176, "URL": "http://dx.doi.org/10.1007/978-3-642-60867-4_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:12:45Z", "timestamp": 1574431965904}, "publisher-location": "Berlin, Heidelberg", "reference-count": 150, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540600619", "type": "print"}, {"value": "9783642798962", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996]]}, "DOI": "10.1007/978-3-642-79896-2_4", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T12:59:31Z", "timestamp": 1323435571000}, "page": "31-53", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Role of Complement in HIV and SIV Pathogenesis and Immunity"], "prefix": "10.1007", "author": [{"given": "D. C.", "family": "Montefiori", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "4_CR1", "doi-asserted-by": "publisher", "first-page": "1091", "DOI": "10.1126/science.2986290", "volume": "228", "author": "JS Allan", "year": "1985", "unstructured": "Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M (1985) Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228:1091\u20131094", "journal-title": "Science"}, {"key": "4_CR2", "doi-asserted-by": "publisher", "first-page": "1935", "DOI": "10.1126/science.1470916", "volume": "258", "author": "LO Arthur", "year": "1991", "unstructured": "Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann J-C, Henderson LE (1991) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935\u20131938", "journal-title": "Science"}, {"key": "4_CR3", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1016/0042-6822(86)90392-2", "volume": "152", "author": "B Banapour", "year": "1986", "unstructured": "Banapour B, Sernatinger J, Levy JA (1986) The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 152:268\u2013271", "journal-title": "Virology"}, {"key": "4_CR4", "doi-asserted-by": "crossref", "first-page": "735", "DOI": "10.1016/S0031-3955(16)36913-9", "volume": "37", "author": "KJ Bart", "year": "1990", "unstructured": "Bart KJ, Lin KF-YC (1990) Vaccine-preventable disease and immunization in the developing world. Pediatr Clin North Am 37:735\u2013756", "journal-title": "Pediatr Clin North Am"}, {"key": "4_CR5", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1172/JCI112876", "volume": "79", "author": "BS Bender", "year": "1987", "unstructured": "Bender BS, Bohnsack JF, Sourlis SH, Frank MM, Quinn TC (1987) Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. J Clin Invest 79: 715\u2013720", "journal-title": "J Clin Invest"}, {"key": "4_CR6", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1016/0140-6736(91)92513-2", "volume": "337", "author": "V Beral", "year": "1991", "unstructured": "Beral V, Peterman T, Berkelman R, Jaffe H (1991) AIDS-associated non-Hodgkin lymphoma. Lancet 337:805\u2013809", "journal-title": "Lancet"}, {"key": "4_CR7", "first-page": "2569", "volume": "141", "author": "JF Bohnsack", "year": "1988", "unstructured": "Bohnsack JF, Cooper NR (1988) CR2 ligands modulate human B cell activation. J Immunol 141:2569\u20132576", "journal-title": "J Immunol"}, {"key": "4_CR8", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1038/340431a0", "volume": "340", "author": "DP Bolognesi", "year": "1989", "unstructured": "Bolognesi DP (1989) Do antibodies enhance the infection of cells by HIV? Nature 340:431\u2013432", "journal-title": "Nature"}, {"key": "4_CR9", "doi-asserted-by": "publisher", "first-page": "1151", "DOI": "10.1084/jem.173.5.1151", "volume": "173", "author": "V Boyer", "year": "1991", "unstructured": "Boyer V, Desgranges C, Trabaud M-A, Fischer E, Kazatchkine MD (1991) Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med 173:1151\u20131158", "journal-title": "J Exp Med"}, {"key": "4_CR10", "doi-asserted-by": "publisher", "first-page": "879", "DOI": "10.1111/j.1365-3083.1992.tb03150.x", "volume": "36", "author": "V Boyer", "year": "1992", "unstructured": "Boyer V, Delibrias C, Noraz N, Fischer E, Kazatchkine MD, Desgranges C (1992) Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol 36:879\u2013883", "journal-title": "Scand J Immunol"}, {"key": "4_CR11", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1353/pbm.1992.0048", "volume": "35", "author": "SB Burke", "year": "1992", "unstructured": "Burke SB (1992) Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk? Perspect Biol Med 35:511\u2013530", "journal-title": "Perspect Biol Med"}, {"key": "4_CR12", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1126/science.1352913", "volume": "257", "author": "PU Cameron", "year": "1992", "unstructured": "Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, Steinman RM (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4\n                        + T cells. Science 257:383\u2013387", "journal-title": "Science"}, {"key": "4_CR13", "first-page": "2747", "volume": "67", "author": "J Cao", "year": "1993", "unstructured": "Cao J, Bergeron L, Helseth E, Thali M, Repke H, Sodroski J (1993) Effects of amino acid changes in the extracellular domain of human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol 67:2747\u20132755", "journal-title": "J Virol"}, {"key": "4_CR14", "first-page": "1755", "volume": "143", "author": "RH Carter", "year": "1989", "unstructured": "Carter RH, Fearon DT (1989) Polymeric C3dg primes human lymphocytes for proliferation induced by anti-IgM. J Immunol 143:1755\u20131760", "journal-title": "J Immunol"}, {"key": "4_CR15", "first-page": "457", "volume": "141", "author": "RH Carter", "year": "1988", "unstructured": "Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141:457\u2013463", "journal-title": "J Immunol"}, {"key": "4_CR16", "doi-asserted-by": "publisher", "first-page": "2915", "DOI": "10.1099/0022-1317-71-12-2915", "volume": "71", "author": "W-R Chen", "year": "1990", "unstructured": "Chen W-R, Tesh RB, Rico-Hesse R (1990) Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 71:2915\u20132922", "journal-title": "J Gen Virol"}, {"key": "4_CR17", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1016/0008-8749(89)90037-3", "volume": "121", "author": "JHM Cohen", "year": "1989", "unstructured": "Cohen JHM, Aubry JP, Revillard JP, Banchereau J, Kazatchkine MD (1989) Human T lymphocytes expressing the C3b/C4b complement receptor type one (CR1, CD35) belong to Fc gamma receptor-positive CD4-positive T cells. Cell Immunol 121: 383\u2013389", "journal-title": "Cell Immunol"}, {"key": "4_CR18", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1073/pnas.82.3.859", "volume": "82", "author": "JL Cole", "year": "1985", "unstructured": "Cole JL, Housley GA Jr, Dykman TR, MacDermott RP, Atkinson JP (1985) Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci USA 82:859", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR19", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1089/aid.1993.9.13", "volume": "9", "author": "MP Cranage", "year": "1993", "unstructured": "Cranage MP, Polyanskaya N, McBride B, Cook N, Ashworth LAE, Dennis M, Baskerville A, Greenaway PJ, Corcoran T, Kitchen P, Rose J, Murphey-Corb M, Desrosiers RC, Stott EJ, Farrar GH (1993) Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 9:13\u201322", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR20", "doi-asserted-by": "publisher", "first-page": "763", "DOI": "10.1038/312763a0", "volume": "312", "author": "AG Dalgleish", "year": "1984", "unstructured": "Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763\u2013766", "journal-title": "Nature"}, {"key": "4_CR21", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1084/jem.170.3.637", "volume": "170", "author": "A Davies", "year": "1989", "unstructured": "Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachman PL, Waldmann H (1989) CD59, an LY-6 like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170:637\u2013654", "journal-title": "J Exp Med"}, {"key": "4_CR22", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1146/annurev.iy.08.040190.003013", "volume": "8", "author": "RC Desrosiers", "year": "1990", "unstructured": "Desrosiers RC (1990) The simian immunodeficiency viruses. Annu Rev Immunol 8:557\u2013578", "journal-title": "Annu Rev Immunol"}, {"key": "4_CR23", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.7326/0003-4819-114-2-119", "volume": "114", "author": "R Dolin", "year": "1991", "unstructured": "Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montef\u00ecori DC, Stabilen DM, Smith GE, Koff WC, and the NIAID AIDS Vaccine Clinical Trials Network (1991) The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. Ann Intern Med 114:119\u2013127", "journal-title": "Ann Intern Med"}, {"key": "4_CR24", "doi-asserted-by": "publisher", "first-page": "648", "DOI": "10.1073/pnas.87.2.648", "volume": "87", "author": "PL Earl", "year": "1990", "unstructured": "Earl PL, Doms RW, Moss B (1990) Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 87: 648\u2013652", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR25", "doi-asserted-by": "publisher", "first-page": "1417", "DOI": "10.1084/jem.174.6.1417", "volume": "174", "author": "CF Ebenbichler", "year": "1991", "unstructured": "Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP (1991) Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 174:1417\u20131424", "journal-title": "J Exp Med"}, {"key": "4_CR26", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1038/362359a0", "volume": "362", "author": "J Embretson", "year": "1993", "unstructured": "Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359\u2013362", "journal-title": "Nature"}, {"key": "4_CR27", "doi-asserted-by": "publisher", "first-page": "1971", "DOI": "10.1073/pnas.75.4.1971", "volume": "75", "author": "DT Fearon", "year": "1978", "unstructured": "Fearon DT (1978) Regulation of membrane sialic acid of B1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75:1971\u20131975", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR28", "doi-asserted-by": "publisher", "first-page": "5867", "DOI": "10.1073/pnas.76.11.5867", "volume": "76", "author": "DT Fearon", "year": "1979", "unstructured": "Fearon DT (1979) Regulation of the amplification of C3 convertase of human complement by an inhibitory protein isolated from the human erythrocyte membrane. Proc Natl Acad Sci USA 76:5867\u20135871", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR29", "doi-asserted-by": "publisher", "first-page": "243", "DOI": "10.1146/annurev.iy.01.040183.001331", "volume": "1", "author": "DT Fearon", "year": "1983", "unstructured": "Fearon DT, Wong WW (1983) Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1:243\u2013271", "journal-title": "Annu Rev Immunol"}, {"key": "4_CR30", "first-page": "865", "volume": "146", "author": "E Fischer", "year": "1991", "unstructured": "Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. Immunology 146:865\u2013869", "journal-title": "Immunology"}, {"key": "4_CR31", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1089/vim.1993.6.135", "volume": "6", "author": "SA Fiscus", "year": "1993", "unstructured": "Fiscus SA, Folds JD, van der Horst CM (1993) Infectious immune complexes in HIV-1 infected patients. Viral Immunol 6:135\u2013141", "journal-title": "Viral Immunol"}, {"key": "4_CR32", "doi-asserted-by": "publisher", "first-page": "322", "DOI": "10.1016/0167-5699(91)90009-I", "volume": "12", "author": "MM Frank", "year": "1991", "unstructured": "Frank MM, Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunol Today 12:322\u2013326", "journal-title": "Immunol Today"}, {"key": "4_CR33", "first-page": "1636", "volume": "137", "author": "LF Fries", "year": "1986", "unstructured": "Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM (1986) Glycoprotein C of herpes simplex virus type 1 is an inhibitor of the complement cascade. J Immunol 137:1636\u20131640", "journal-title": "J Immunol"}, {"key": "4_CR34", "first-page": "11760", "volume": "263", "author": "H Geyer", "year": "1988", "unstructured": "Geyer H, Holschbach C, Hunsman C, Schneider J (1988) Carbohydrates of human immunodeficiency virus: structures of oligosaccharides linked to the envelope glycoprotein gp120. J Biol Chem 263:11760\u201311768", "journal-title": "J Biol Chem"}, {"key": "4_CR35", "first-page": "541", "volume": "65", "author": "GS Gras", "year": "1991", "unstructured": "Gras GS, Dormont D (1991) Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line. J Virol 65: 541\u2013545", "journal-title": "J Virol"}, {"key": "4_CR36", "first-page": "1808", "volume": "81", "author": "G Gras", "year": "1993", "unstructured": "Gras G, Richard Y, Roques P, Olivier R, Dormont D (1993) Complement and virus- specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1. Blood 81:1808\u20131818", "journal-title": "Blood"}, {"key": "4_CR37", "first-page": "301", "volume": "31", "author": "SB Halstead", "year": "1982", "unstructured": "Halstead SB (1982) Immune enhancement of viral infection. Prog Allergy 31: 301\u2013364", "journal-title": "Prog Allergy"}, {"key": "4_CR38", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1038/265739a0", "volume": "265", "author": "SB Halstead", "year": "1977", "unstructured": "Halstead SB, O\u2019Rourke EJ (1977) Antibody enhanced dengue virus infection in primate leukocytes. Nature 265:739\u2013741", "journal-title": "Nature"}, {"key": "4_CR39", "first-page": "908", "volume": "22", "author": "S Harada", "year": "1985", "unstructured": "Harada S, Yoshiyama H, Yamamoto N (1985) Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems. J Clin Microbiol 22:908\u2013911", "journal-title": "J Clin Microbiol"}, {"key": "4_CR40", "first-page": "71", "volume": "46", "author": "RL Hirsch", "year": "1982", "unstructured": "Hirsch RL (1982) The complement system: its importance in the host response to viral infection. Microbiol Rev 46:71\u201385", "journal-title": "Microbiol Rev"}, {"key": "4_CR41", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1007/BF01315298", "volume": "87", "author": "RL Hirsch", "year": "1986", "unstructured": "Hirsch RL, Wolinsky JS, Winkelstein JA (1986) Activation of the alternative complement pathway by mumps-infected cells: relationship to viral neuraminidase activity. Arch Virol 87:181\u2013188", "journal-title": "Arch Virol"}, {"key": "4_CR42", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1038/373123a0", "volume": "373", "author": "DD Ho", "year": "1995", "unstructured": "Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123\u2013126", "journal-title": "Nature"}, {"key": "4_CR43", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1016/0167-5699(88)91206-6", "volume": "9", "author": "N Hogg", "year": "1988", "unstructured": "Hogg N (1988) The structure and function of Fc receptors. Immunol Today 9: 185\u2013187", "journal-title": "Immunol Today"}, {"key": "4_CR44", "doi-asserted-by": "publisher", "first-page": "608", "DOI": "10.1056/NEJM198809083191004", "volume": "319", "author": "CH Hoke", "year": "1988", "unstructured": "Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S-O, Gingrich JB, Latendresse J, Fukai K, Burke DS (1988) Protection against japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608\u2013614", "journal-title": "N Engl J Med"}, {"key": "4_CR45", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1172/JCI114172", "volume": "84", "author": "MH Holguin", "year": "1989", "unstructured": "Holguin MH, Fredrick LR, Bernshaw NJ, Wilcox LA, Parker CJ (1989) Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:7\u201317", "journal-title": "J Clin Invest"}, {"key": "4_CR46", "doi-asserted-by": "publisher", "first-page": "1357", "DOI": "10.1126/science.2786647", "volume": "244", "author": "J Homsy", "year": "1989", "unstructured": "Homsy J, Meyer M, Tateno M, Clarkson S, Levy JA (1989) The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357\u20131360", "journal-title": "Science"}, {"key": "4_CR47", "first-page": "721", "volume": "60", "author": "RD Hortsmann", "year": "1992", "unstructured": "Hortsmann RD (1992) Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternate pathway of complement activation. Infect Immun 60:721\u2013727", "journal-title": "Infect Immun"}, {"key": "4_CR48", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1089/aid.1.1986.2.235", "volume": "2", "author": "Y Inada", "year": "1986", "unstructured": "Inada Y, Lange M, McKinley GF, Sonnabend JA, Fonville TW, Kanemitsu T, Tanaka M, Clark WS (1986) Hematologic correlates and the role of erythrocyte CR1 (C#b receptors) in the development of AIDS. AIDS Res 2:235\u2013247", "journal-title": "AIDS Res"}, {"key": "4_CR49", "first-page": "3398", "volume": "66", "author": "CJ Issel", "year": "1992", "unstructured": "Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC (1992) Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 66:3398\u20133408", "journal-title": "J Virol"}, {"key": "4_CR50", "doi-asserted-by": "publisher", "first-page": "2175", "DOI": "10.1073/pnas.89.6.2175", "volume": "89", "author": "PR Johnson", "year": "1992", "unstructured": "Johnson PR, Montef\u00ecori DC, Goldstein S, Hamm TE, Zhou J, Kitov S, Haigwood NL, Misher L, London WT, Gerin JL, Allison A, Purcell RH, Chanock RM, Hirsch VM (1992) Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci USA 89: 2175\u20132179", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR51", "first-page": "1065", "volume": "150", "author": "P Joling", "year": "1993", "unstructured": "Joling P, Bakker LJ, Van Strijp JAG, Meerloo T, de Graaf L, Dekker MEM, Goudsmit J, Verhoef J, Schuurman H-J (1993) Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol 150:1065\u20131073", "journal-title": "J Immunol"}, {"key": "4_CR52", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1097/00002030-198903000-00002", "volume": "3", "author": "T Jouault", "year": "1989", "unstructured": "Jouault T, Chapuis F, Olivier R, Parravicini C, Bahraoui E, Gluckman J-C (1989) HIV infection of monocytic cells: role of antibody-mediated virus binding to Fc- gamma receptors. AIDS 3:125\u2013133", "journal-title": "AIDS"}, {"key": "4_CR53", "first-page": "89", "volume": "1", "author": "M-H Jouvin", "year": "1987", "unstructured": "Jouvin M-H, Rozenbaum W, Russo R, Kazatchkine MD (1987) Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. AIDS 1: 89\u201394", "journal-title": "AIDS"}, {"key": "4_CR54", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1097/00002030-199103000-00004", "volume": "5", "author": "RA June", "year": "1991", "unstructured": "June RA, Schade SZ, Bankowski MJ, Kuhns M, McNamara A, Lint TF, Landay AL, Spear GT (1991) Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS 5:269\u2013274", "journal-title": "AIDS"}, {"key": "4_CR55", "first-page": "59", "volume": "75", "author": "RA June", "year": "1992", "unstructured": "June RA, Landay AL, Stefanik K, Lint TF, Spear GT (1992) Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4\n                        + cells in HIV-infected persons. Immunology 75:59\u201365", "journal-title": "Immunology"}, {"key": "4_CR56", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1126/science.6330889", "volume": "225", "author": "VS Kalyanaraman", "year": "1984", "unstructured": "Kalyanaraman VS, Cabradilla CD, Getchell JP, Narayana R, Braff EH, Chermann J-C, Barre-Sinnoussi F, Montagnier L, Spira TJ, Kaplan J, Fishbein D, Jaffe HW, Curran JW, Francis DP (1984) Antibodies to the core protein of lymphadenopathy virus (LAV) in patients with AIDS. Science 225:321\u2013323", "journal-title": "Science"}, {"key": "4_CR57", "doi-asserted-by": "publisher", "first-page": "5535", "DOI": "10.1073/pnas.82.16.5535", "volume": "82", "author": "LS Kaminsky", "year": "1985", "unstructured": "Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA (1985) High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)- associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci USA 82:5535\u20135539", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR58", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1016/0167-5699(91)90001-A", "volume": "12", "author": "T Kinoshita", "year": "1991", "unstructured": "Kinoshita T (1991) Biology of complement: the overture. Immunol Today 12:291\u2013295", "journal-title": "Immunol Today"}, {"key": "4_CR59", "doi-asserted-by": "publisher", "first-page": "737", "DOI": "10.1126/science.8303282", "volume": "263", "author": "DD Kiprov", "year": "1994", "unstructured": "Kiprov DD, Sheppard HW, Hanson CV (1994) Alloimmunization to prevent AIDS? Science 263:737\u2013738", "journal-title": "Science"}, {"key": "4_CR60", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1038/312767a0", "volume": "312", "author": "D Klatzmann", "year": "1984", "unstructured": "Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767\u2013770", "journal-title": "Nature"}, {"key": "4_CR61", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.4269/ajtmh.1989.40.444", "volume": "40", "author": "SC Kliks", "year": "1989", "unstructured": "Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444\u2013451", "journal-title": "Am J Trop Med Hyg"}, {"key": "4_CR62", "doi-asserted-by": "publisher", "first-page": "827", "DOI": "10.1126/science.2237434", "volume": "250", "author": "GJ Kotwal", "year": "1990", "unstructured": "Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827\u2013830", "journal-title": "Science"}, {"key": "4_CR63", "doi-asserted-by": "publisher", "first-page": "1351", "DOI": "10.1126/science.3629244", "volume": "237", "author": "M Kowalski", "year": "1987", "unstructured": "Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, Sodroski J (1987) Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351\u20131355", "journal-title": "Science"}, {"key": "4_CR64", "doi-asserted-by": "publisher", "first-page": "292", "DOI": "10.1126/science.1549775", "volume": "255", "author": "AJ Langlois", "year": "1992", "unstructured": "Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML Bolognesi DP (1992a) The ability of certain SIV vaccines to provoke reactions against normal cells. Science 255:292\u2013293", "journal-title": "Science"}, {"key": "4_CR65", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1089/aid.1992.8.1641", "volume": "8", "author": "AJ Langlois", "year": "1992", "unstructured": "Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP (1992b) Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 8:1641\u20131652", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR66", "first-page": "103", "volume": "3", "author": "C Larcher", "year": "1990", "unstructured": "Larcher C, Schultz TF, Hofbauer J, Hengster P, Romani N, Wachter H, Dierich MP (1990) Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells. J Acquir Immune Defic Syndr 3:103\u2013108", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "4_CR67", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.1016/0092-8674(87)90524-1", "volume": "50", "author": "LA Lasky", "year": "1987", "unstructured": "Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ (1987) Delineation of a region of the human immunodeficiency virus gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975\u2013985", "journal-title": "Cell"}, {"key": "4_CR68", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1038/355684a0", "volume": "355", "author": "R LeGrand", "year": "1992", "unstructured": "LeGrand R, Vasli B, Vogt G, Roques P, Humbert M, Dormont D, Aubertin AM (1992) AIDS vaccine developments. Nature 355:684", "journal-title": "Nature"}, {"key": "4_CR69", "doi-asserted-by": "publisher", "first-page": "4601", "DOI": "10.1073/pnas.84.13.4601", "volume": "84", "author": "HK Lyerly", "year": "1987", "unstructured": "Lyerly HK, Matthews TJ, Langlois AJ, Bolognesi DP, Weinhold, KJ (1987) Human T- cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as targets for immune attack. Proc Natl Acad Sci USA 84:4601\u20134605", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "4_CR70", "first-page": "577", "volume": "67", "author": "R Marcus", "year": "1989", "unstructured": "Marcus R, Kay K, Mann JM (1989) Transmission of human immunodeficiency virus type (HIV) in healthcare settings worlwide. Bull WHO 67:577\u2013582", "journal-title": "Bull WHO"}, {"key": "4_CR71", "doi-asserted-by": "publisher", "first-page": "903", "DOI": "10.1097/00002030-199307000-00001", "volume": "7", "author": "P Marschang", "year": "1993", "unstructured": "Marschang P, Gurtler L, Totsch M, Thielens NM, Arlaud GJ, Hittmair A, Katinger H, Dierich MP (1993) HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells. AIDS 7:903\u2013910", "journal-title": "AIDS"}, {"key": "4_CR72", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1002/eji.1830250147", "volume": "25", "author": "P Marschang", "year": "1995", "unstructured": "Marschang P, Sodroski J, Wurzner R, Dierich MP (1995) Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol 25:285\u2013290", "journal-title": "Eur J Immunol"}, {"key": "4_CR73", "first-page": "3720", "volume": "138", "author": "O Martinez-Maza", "year": "1987", "unstructured": "Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV (1987) Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 138:3720\u20133727", "journal-title": "J Immunol"}, {"key": "4_CR74", "doi-asserted-by": "publisher", "first-page": "1175", "DOI": "10.1089/aid.1993.9.1175", "volume": "9", "author": "JR Mascola", "year": "1993", "unstructured": "Mascola JR, Matthieson BJ, Zack PM, Walker MC, Halstead SB, Burke DS (1993) Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses 9:1175\u20131184", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR75", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1084/jem.173.1.55", "volume": "173", "author": "AK Matsumoto", "year": "1991", "unstructured": "Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173:55\u201364", "journal-title": "J Exp Med"}, {"key": "4_CR76", "doi-asserted-by": "publisher", "first-page": "1088", "DOI": "10.1093/infdis/158.5.1088", "volume": "158", "author": "TM McHugh", "year": "1988", "unstructured": "McHugh TM, Stites DP, Busch MP, Krowka JF, Stricker RB, Hollander H (1988) Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients. J Infect Dis 158:1088\u20131091", "journal-title": "J Infect Dis"}, {"key": "4_CR77", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1016/0042-6822(81)90230-0", "volume": "114", "author": "JJ McSharry", "year": "1981", "unstructured": "McSharry JJ, Pickering RJ, Caliguiri LA (1981) Activation of the alternate complement pathway by enveloped viruses containing limited amounts of sialic acid. Virology 114:507\u2013514", "journal-title": "Virology"}, {"key": "4_CR78", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1099/0022-1317-74-1-129", "volume": "74", "author": "T Meerloo", "year": "1993", "unstructured": "Meerloo T, Sheikh MA, Bloem AC, de Ronde A, Schutten M, van Els CAC, Roholl PJM, Goudsmit J, Schuurman H-J (1993) Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. J Gen Virol 74: 129\u2013135", "journal-title": "J Gen Virol"}, {"key": "4_CR79", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1038/317264a0", "volume": "317", "author": "F Melchers", "year": "1985", "unstructured": "Melchers F, Erdei A, Schultz T, Dierich MP (1985) Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317: 264\u2013267", "journal-title": "Nature"}, {"key": "4_CR80", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1097/00002030-199501000-00004", "volume": "9", "author": "WM Mitchell", "year": "1995", "unstructured": "Mitchell WM, Torres J, Johnson PR, Hirsch V, Yilma T, Gardner MB, Robinson WE Jr (1995) Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS 9:27\u201334", "journal-title": "AIDS"}, {"key": "4_CR81", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1042/bj2540599", "volume": "254", "author": "T Mizouchi", "year": "1988", "unstructured": "Mizouchi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T (1988) Carbohydrate structures of the human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biochem J 254:599\u2013605", "journal-title": "Biochem J"}, {"key": "4_CR82", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/0166-3542(89)90025-9", "volume": "11", "author": "DC Montefiori", "year": "1989", "unstructured": "Montefiori DC, Robinson WE, Mitchell WM (1989) Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors. Antiviral Res 11:137\u2013146", "journal-title": "Antiviral Res"}, {"key": "4_CR83", "first-page": "5223", "volume": "64", "author": "DC Montefiori", "year": "1990", "unstructured": "Montefiori DC, Murphey-Corb M, Desrosiers RC, Daniel MD (1990 a) Complementmediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus. J Virol 64: 5223\u20135225", "journal-title": "J Virol"}, {"key": "4_CR84", "first-page": "113", "volume": "64", "author": "DC Montefiori", "year": "1990", "unstructured": "Montefiori DC, Robinson WE, Hirsch VM, Modliszewski A, Mitchell WM, Johnson PR (1990b) Antibody-dependent enhancement of simian immunodeficiency virus infection in vitro by plasma from SIV-infected rhesus macaques. J Virol 64:113\u2013119", "journal-title": "J Virol"}, {"key": "4_CR85", "first-page": "269", "volume": "19", "author": "DC Montefiori", "year": "1990", "unstructured": "Montefiori DC, Robinson WE Jr, Hirsch VM, Modliszewski A, Mitchell WM, Johnson PR (1990c) Antibody-dependent enhancement of simian immunodeficiency virus infection: complement pathway required and cross reactivity between macaque and sooty mangabey isolates. J Med Primatol 19:269\u2013278", "journal-title": "J Med Primatol"}, {"key": "4_CR86", "doi-asserted-by": "publisher", "first-page": "572", "DOI": "10.1111/j.1749-6632.1990.tb17897.x", "volume": "616", "author": "DC Montefiori", "year": "1990", "unstructured": "Montefiori DC, Robinson WE, Modliszewski A, Mitchell WM (1990d) Complement- mediated enhancement of HIV-1 infection reverses the anti-HIV-1 activity of castanospermine. Ann N Y Acad Sci 616:572\u2013574", "journal-title": "Ann N Y Acad Sci"}, {"key": "4_CR87", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1038/354439c0", "volume": "354", "author": "DC Montefiori", "year": "1991", "unstructured": "Montefiori DC, Hirsch VM, Johnson PR (1991a) AIDS response. Nature 354:440\u2013441", "journal-title": "Nature"}, {"key": "4_CR88", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1097/00002030-199105000-00006", "volume": "5", "author": "DC Montefiori", "year": "1991", "unstructured": "Montefiori DC, Lefkowitz LB, Keller RE, Holmberg V, Sandstrom E, Phair JP, and the Multicenter AIDS Cohort Study Group (1991b) Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma and sera from HIV-1 infected persons. AIDS 5:513\u2013517", "journal-title": "AIDS"}, {"key": "4_CR89", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1007/BF00918855", "volume": "12", "author": "DC Montef\u00ecori", "year": "1992", "unstructured": "Montef\u00ecori DC, Graham BS, Kliks S, Wright PF, and the NIAID AIDS Vaccine Clinical Trials Nework (1992 a) Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. J Clin Immunol 12: 429\u2013439", "journal-title": "J Clin Immunol"}, {"key": "4_CR90", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1111/j.1365-2249.1992.tb05855.x", "volume": "90", "author": "DC Montef\u00ecori", "year": "1992", "unstructured": "Montef\u00ecori DC, Zhou J, Shaff DI (1992 b) CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody. Clin Exp Immunol 90:383\u2013389", "journal-title": "Clin Exp Immunol"}, {"key": "4_CR91", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1006/viro.1994.1622", "volume": "205", "author": "DC Montefiori", "year": "1994", "unstructured": "Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR (1994a) Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82\u201392", "journal-title": "Virology"}, {"key": "4_CR92", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1093/infdis/170.2.429", "volume": "170", "author": "DC Montefiori", "year": "1994", "unstructured": "Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM (1994 b) Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor, CR1 (CD35), and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 170:429\u2013432", "journal-title": "J Infect Dis"}, {"key": "4_CR93", "first-page": "2699", "volume": "67", "author": "DC Montefiori", "year": "1993", "unstructured": "Montefiori DC, Stewart K, Ahearn JM, Zhou JT, Zhou JY (1993) Complement-mediated binding of naturally glycosylated and glycosylation-modif\u00eced human immunodeficiency virus type 1 to human CR2 (CD21). J Virol 67:2699\u20132706", "journal-title": "J Virol"}, {"key": "4_CR94", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1089/aid.1995.11.963", "volume": "11", "author": "DC Montefiori", "year": "1995", "unstructured": "Montefiori DC, Reimann KA, Letvin NL, Zhou J, Hu S-L (1995) Infection-enhancing antibodies in the SIV/macaque model of acute primary infection and vaccine protection. AIDS Res Hum Retroviruses 11:963\u2013970", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR95", "unstructured": "Montefiori DC (1995) New insights into the role of host cell proteins in antiviral vaccine protection. AIDS Res Hum Retroviruses (in press)", "DOI": "10.1089/aid.1995.11.1429", "doi-asserted-by": "crossref"}, {"key": "4_CR96", "unstructured": "Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS (1996) Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term nonprogressors. J Infect Dis (in press)", "DOI": "10.1093/infdis/173.1.60", "doi-asserted-by": "crossref"}, {"key": "4_CR97", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1016/0090-1229(86)90196-0", "volume": "40", "author": "WJW Morrow", "year": "1986", "unstructured": "Morrow WJW, Wharton M, Stricker RB, Levy JA (1986) Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS- associated retrovirus. Clin Immunol Immunopathol 40:515\u2013524", "journal-title": "Clin Immunol Immunopathol"}, {"key": "4_CR98", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1146/annurev.bi.57.070188.001541", "volume": "57", "author": "H Muller-Eberhard", "year": "1988", "unstructured": "Muller-Eberhard H (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57:321\u2013347", "journal-title": "Annu Rev Biochem"}, {"key": "4_CR99", "first-page": "184", "volume": "129", "author": "A Nicholson-Weller", "year": "1982", "unstructured": "Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF (1982) Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129:184\u2013189", "journal-title": "J Immunol"}, {"key": "4_CR100", "first-page": "2458", "volume": "139", "author": "EA Ojo-Amaize", "year": "1987", "unstructured": "Ojo-Amaize EA, Nishanian P, Keith DE Jr, Houghton RL, Heitjan DF, Fahey JL, Giorgi JV (1987) Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol 139:2458\u20132463", "journal-title": "J Immunol"}, {"key": "4_CR101", "doi-asserted-by": "publisher", "first-page": "1553", "DOI": "10.1016/0006-291X(89)90852-8", "volume": "162", "author": "H Okada", "year": "1989", "unstructured": "Okada H, Nagami Y, Takahashi K, Okada N, Hideshima T, Takizawa H, Kondo J (1989) 20 KDa homologous restriction factor of complement resembles T cell activating protein. Biochem Biophys Res Commun 162:1553\u20131559", "journal-title": "Biochem Biophys Res Commun"}, {"key": "4_CR102", "doi-asserted-by": "publisher", "first-page": "1157", "DOI": "10.1089/aid.1993.9.1157", "volume": "9", "author": "RJ Orentas", "year": "1993", "unstructured": "Orentas RJ, Hildreth JEK (1993) Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 9: 1157\u20131165", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR103", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1038/355684b0", "volume": "355", "author": "A Osterhaus", "year": "1992", "unstructured": "Osterhaus A, de Vries P, Heeney J (1992) AIDS vaccine developments. Nature 355: 684\u2013685", "journal-title": "Nature"}, {"key": "4_CR104", "first-page": "977", "volume": "124", "author": "M Pangburn", "year": "1980", "unstructured": "Pangburn M, Morrison D, Schreiber R, Muller-Eberhard H (1980) Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J Immunol 124:977\u2013982", "journal-title": "J Immunol"}, {"key": "4_CR105", "first-page": "500", "volume": "70", "author": "R Perricone", "year": "1987", "unstructured": "Perricone R, Fontana L, De Carolis C, Carini C, Sirianni MC, Aiuti F (1987) Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphadenopathy syndrome (LAS). Clin Exp Immunol 70:500\u2013507", "journal-title": "Clin Exp Immunol"}, {"key": "4_CR106", "doi-asserted-by": "publisher", "first-page": "1749", "DOI": "10.1126/science.8096089", "volume": "259", "author": "M Piatak", "year": "1993", "unstructured": "Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk K-C, Hahn BH, Shaw GM, Lifson JD (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749\u20131754", "journal-title": "Science"}, {"key": "4_CR107", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1016/S0065-3527(08)60268-7", "volume": "31", "author": "JS Porterfield", "year": "1986", "unstructured": "Porterfield JS (1986) Antibody-dependent enhancement of viral infectivity. Adv Virus Res 31:335\u2013355", "journal-title": "Adv Virus Res"}, {"key": "4_CR108", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1016/0042-6822(92)90745-B", "volume": "188", "author": "PR Post", "year": "1992", "unstructured": "Post PR, Santos CD, Carvalho R, Cruz ACR, Rice CM, Galler R (1992) Heterogeneity in envelope protein sequences and N-linked glycosylation among yellow fever virus vaccine strains. Virology 188:160\u2013167", "journal-title": "Virology"}, {"key": "4_CR109", "first-page": "2362", "volume": "68", "author": "KA Reimann", "year": "1994", "unstructured": "Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, Letvin NL (1994) Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68:2362\u20132370", "journal-title": "J Virol"}, {"key": "4_CR110", "doi-asserted-by": "publisher", "first-page": "961", "DOI": "10.1097/00002030-199010000-00003", "volume": "4", "author": "EC Reisinger", "year": "1990", "unstructured": "Reisinger EC, Vogetseder W, Berzow D, Kofler D, Bitterlich G, Lehr HA, Wachter H, Dierich MP (1990) Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS 4:961\u2013965", "journal-title": "AIDS"}, {"key": "4_CR111", "first-page": "2687", "volume": "135", "author": "M Reynes", "year": "1985", "unstructured": "Reynes M, Aubert JP, Cohen JHM, Audouin J, Tricottet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135:2687\u20132694", "journal-title": "J Immunol"}, {"key": "4_CR112", "doi-asserted-by": "publisher", "first-page": "790", "DOI": "10.1016/S0140-6736(88)91657-1", "volume": "1", "author": "WE Robinson", "year": "1988", "unstructured": "Robinson WE, Montefiori DC, Mitchell WM (1988) Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790\u2013794", "journal-title": "Lancet"}, {"key": "4_CR113", "first-page": "33", "volume": "2", "author": "WE Robinson", "year": "1989", "unstructured": "Robinson WE, Montefiori DC, Gillespie DH, Mitchell WM (1989) Complement- mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA synthesis and infectious virus release. J Acquir Immune Defic Syndr 2:33\u201342", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "4_CR114", "first-page": "5301", "volume": "64", "author": "WE Robinson", "year": "1990", "unstructured": "Robinson WE, Kawamura T, Lake D, Masuho Y, Mitchell WM, Hersh EM (1990a) Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol 64:5301\u20135305", "journal-title": "J Virol"}, {"key": "4_CR115", "doi-asserted-by": "publisher", "first-page": "600", "DOI": "10.1016/0042-6822(90)90449-2", "volume": "175", "author": "WE Robinson", "year": "1990", "unstructured": "Robinson WE, Montefiori DC, Mitchell WM (1990 b) Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175:600\u2013604", "journal-title": "Virology"}, {"key": "4_CR116", "first-page": "4169", "volume": "65", "author": "WE Robinson", "year": "1991", "unstructured": "Robinson WE, Gorny MW, Xu J-Y, Mitchell WM, Zolla-Pazner S (1991) Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 65:4169\u20134176", "journal-title": "J Virol"}, {"key": "4_CR117", "doi-asserted-by": "publisher", "first-page": "501", "DOI": "10.1084/jem.182.2.501", "volume": "182", "author": "M Saifuddin", "year": "1995", "unstructured": "Saifuddin M, Parker CJ, Peeples ME, Gorny MK, Zolla-Pazner S, Ghassemi M, Rooney IA, Atkinson JP, Spear GT (1995) Role of virion-associated glycosylphos- phatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 182:501\u2013509", "journal-title": "J Exp Med"}, {"key": "4_CR118", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1126/science.6324345", "volume": "224", "author": "MG Sarngadharan", "year": "1984", "unstructured": "Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC (1984) Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224:506\u2013508", "journal-title": "Science"}, {"key": "4_CR119", "first-page": "1772", "volume": "136", "author": "S Schonermark", "year": "1986", "unstructured": "Schonermark S, Rauterberg EW, Shin ML, Loke S, Roelcke D, Hansch GM (1986) Homologous species restriction in lysis of human erythrocytes: a membrane- derived protein with C8-binding capacity functions as an inhibitor. J Immunol 136:1772", "journal-title": "J Immunol"}, {"key": "4_CR120", "doi-asserted-by": "publisher", "first-page": "5175", "DOI": "10.1021/bi00668a035", "volume": "15", "author": "V Schumaker", "year": "1976", "unstructured": "Schumaker V, Calcott M, Spiegelberg H, Muller-Eberhard H (1976) Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement. Biochemistry 15:5175\u20135181", "journal-title": "Biochemistry"}, {"key": "4_CR121", "doi-asserted-by": "publisher", "first-page": "1227", "DOI": "10.1093/infdis/162.6.1227", "volume": "162", "author": "G Senaldi", "year": "1990", "unstructured": "Senaldi G, Peakman M, McManus T, Davies ET, Tee DEH, Vergani D (1990) Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 162:1227\u20131232", "journal-title": "J Infect Dis"}, {"key": "4_CR122", "doi-asserted-by": "publisher", "first-page": "912", "DOI": "10.1038/bjc.1992.384", "volume": "66", "author": "D Serraino", "year": "1992", "unstructured": "Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB, Ancelle- Park RA (1992) The epidemiology of AIDS-associated non-Hodgkin\u2019s lymphoma in the World Health Organization European region. Br J Cancer 66:912\u2013916", "journal-title": "Br J Cancer"}, {"key": "4_CR123", "first-page": "4309", "volume": "65", "author": "PP Shadduck", "year": "1991", "unstructured": "Shadduck PP, Weinberg JB, Haney AF, Bartlett JA, Langlois AJ, Bolognesi DP, Matthews TJ (1991) Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. J Virol 65:4309\u20134316", "journal-title": "J Virol"}, {"key": "4_CR124", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1126/science.8211133", "volume": "262", "author": "GM Shearer", "year": "1993", "unstructured": "Shearer GM, Clerici M, Dalgleish A (1993) Alloimmunization as an AIDS vaccine? Science 262:161\u2013162", "journal-title": "Science"}, {"key": "4_CR125", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1172/JCI115621", "volume": "89", "author": "A Shirai", "year": "1992", "unstructured": "Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM (1992) Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 89:561\u2013566", "journal-title": "J Clin Invest"}, {"key": "4_CR126", "first-page": "857", "volume": "55", "author": "ML Smiley", "year": "1985", "unstructured": "Smiley ML, Friedman HM (1985) Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. J Virol 55:857\u2013861", "journal-title": "J Virol"}, {"key": "4_CR127", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/0165-2478(89)90180-6", "volume": "22", "author": "BM Soelder", "year": "1989", "unstructured": "Soelder BM, Schultz TF, Hengster P, Lower J, Larcher C, Bitterlich G, Kurth R, Wachter H, Dierich MP (1989 a) HIV and HIV-infected cells differentially activate the human complement system independently of antibody. Immunol Lett 22: 135\u2013146", "journal-title": "Immunol Lett"}, {"key": "4_CR128", "doi-asserted-by": "publisher", "first-page": "271", "DOI": "10.1016/S0140-6736(89)90452-2", "volume": "2", "author": "BM Soelder", "year": "1989", "unstructured": "Soelder BM, Reisinger EC, Koefler D, Bitterlich G, Wachter H, Dierich MP (1989b) Complement receptors: another port of entry for HIV. Lancet 2:271\u2013272", "journal-title": "Lancet"}, {"key": "4_CR129", "doi-asserted-by": "publisher", "first-page": "579", "DOI": "10.1089/aid.1991.7.579", "volume": "7", "author": "GT Spear", "year": "1991", "unstructured": "Spear GT, Jiang H, Sullivan BL, Gewurz H, Landay AL, Lint TF (1991) Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphoptropic virus-I (HTLV-I) coinfected cells. AIDS Res Hum Retroviruses 7:579\u2013585", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR130", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1006/viro.1993.1398", "volume": "195", "author": "GT Spear", "year": "1993", "unstructured": "Spear GT, Takefman DM, Sullivan BL, Landay AL, Jennings MB, Carlson JR (1993) Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology 195:475\u2013480", "journal-title": "Virology"}, {"key": "4_CR131", "first-page": "15", "volume": "140", "author": "H Spiegel", "year": "1992", "unstructured": "Spiegel H, Herbst H, Niedobitek G, Foss H-D, Stein H (1992) Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4\n                        + T-helper cells. Am J Pathol 140:15\u201322", "journal-title": "Am J Pathol"}, {"key": "4_CR132", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1002/eji.1830240203", "volume": "24", "author": "H Stoiber", "year": "1994", "unstructured": "Stoiber H, Thielens NM, Ebenbichler C, Arlaud GJ, Dierich MP (1994) The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology. Eur J Immunol 24:294\u2013300", "journal-title": "Eur J Immunol"}, {"key": "4_CR133", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1038/353393a0", "volume": "353", "author": "EJ Stott", "year": "1991", "unstructured": "Stott EJ (1991) Anti-cell antibody in macaques. Nature 353:393", "journal-title": "Nature"}, {"key": "4_CR134", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1093/oxfordjournals.jbchem.a122524", "volume": "104", "author": "Y Sugita", "year": "1988", "unstructured": "Sugita Y, Nakano Y, Tomita M (1988) Isolation from erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane chanels. J Biochem (Tokyo) 104:633\u2013637", "journal-title": "J Biochem (Tokyo)"}, {"key": "4_CR135", "first-page": "6028", "volume": "152", "author": "C Susal", "year": "1994", "unstructured": "Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G (1994) Complement activation by recombinant HIV-1 glycoprotein gp120. J Immunol 152:6028\u20136034", "journal-title": "J Immunol"}, {"key": "4_CR136", "doi-asserted-by": "publisher", "first-page": "580", "DOI": "10.1126/science.2972065", "volume": "242", "author": "A Takeda", "year": "1988", "unstructured": "Takeda A, Tuazon CU, Ennis FA (1988) Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580\u2013585", "journal-title": "Science"}, {"key": "4_CR137", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1172/JCI112688", "volume": "78", "author": "FA Tausk", "year": "1986", "unstructured": "Tausk FA, McCutchan JA, Spechko P, Schreiber RD, Gigli I (1986) Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 78:977\u2013982", "journal-title": "J Clin Invest"}, {"key": "4_CR138", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1084/jem.65.6.787", "volume": "65", "author": "M Theiler", "year": "1937", "unstructured": "Theiler M, Smith HH (1937) The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65:787\u2013800", "journal-title": "J Exp Med"}, {"key": "4_CR139", "doi-asserted-by": "publisher", "first-page": "106", "DOI": "10.1111/j.1365-2249.1993.tb05955.x", "volume": "92", "author": "N Thieblemont", "year": "1993", "unstructured": "Thieblemont N, Haeffner-Cavaillon N, Ledur A, L\u2019Age-Stehr J, Ziegler-Heitbrock HWL Kazatchkine MD (1993a) CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin Exp Immunol 92:106\u2013113", "journal-title": "Clin Exp Immunol"}, {"key": "4_CR140", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1089/aid.1993.9.229", "volume": "9", "author": "N Thieblemont", "year": "1993", "unstructured": "Thieblemont N, Haeffner-Cavaillon N, Weiss L, Maillet F, Kazatchkine MD (1993b) Complement activation by gp160 glycoprotein of HIV-1. AIDS Res Hum Retroviruses 9:229\u2013233", "journal-title": "AIDS Res Hum Retroviruses"}, {"key": "4_CR141", "first-page": "6583", "volume": "151", "author": "NM Thielens", "year": "1993", "unstructured": "Thielens NM, Bally IM, Ebenbichler CF, Dierich, MP, Arlaud GJ (1993) Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J Immunol 151: 6583\u20136592", "journal-title": "J Immunol"}, {"key": "4_CR142", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1111/j.1365-2249.1994.tb06040.x", "volume": "96", "author": "FD Toth", "year": "1994", "unstructured": "Toth FD, Mosborg-Petersen P, Kiss J, Aboagye-Mathiesen G, Zdravkovic M, Hager H, Aranyosi J, Lampe L, Ebbesen P (1994) Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro. Clin Exp Immunol 96:389\u2013394", "journal-title": "Clin Exp Immunol"}, {"key": "4_CR143", "doi-asserted-by": "publisher", "first-page": "1791", "DOI": "10.1084/jem.171.5.1791", "volume": "171", "author": "M Tremblay", "year": "1990", "unstructured": "Tremblay M, Meloche S, Sekaly RP, Wainberg MA (1990) Complement receptor type 2 mediates enhancement of human immunodeficiency virus type 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med 171:1791\u20131796", "journal-title": "J Exp Med"}, {"key": "4_CR144", "first-page": "1640", "volume": "144", "author": "GC Tsokos", "year": "1990", "unstructured": "Tsokos GC, Lambris JD, Finkelman FD, Anastassiou ED, June CH (1990) Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J Immunol 144:1640\u20131645", "journal-title": "J Immunol"}, {"key": "4_CR145", "doi-asserted-by": "publisher", "first-page": "1402", "DOI": "10.1126/science.2994223", "volume": "229", "author": "FM Veronese", "year": "1985", "unstructured": "Veronese FM, DeVico AL, Copeland TD, Droszland S, Gallo RC, Sarngadharan MG (1985) Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229:1402\u20131405", "journal-title": "Science"}, {"key": "4_CR146", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1006/viro.1994.1120", "volume": "199", "author": "SZ-S Wang", "year": "1994", "unstructured": "Wang SZ-S, Rushlow KE, Issel CJ, Cook RF, Cook SJ, Raabe ML, Chong Y-H, Costa L, Montelaro RC (1994) Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247\u2013251", "journal-title": "Virology"}, {"key": "4_CR147", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1038/373117a0", "volume": "373", "author": "X Wei", "year": "1995", "unstructured": "Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson, JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117\u2013122", "journal-title": "Nature"}, {"key": "4_CR148", "first-page": "5674", "volume": "64", "author": "CD Weiss", "year": "1990", "unstructured": "Weiss CD, Levy JA, White JM (1990) Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J Virol 64:5674\u20135677", "journal-title": "J Virol"}, {"key": "4_CR149", "first-page": "824", "volume": "66", "author": "BS Wilson", "year": "1985", "unstructured": "Wilson BS, Platt JL, Kay NE (1985) Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood 66:824\u2013829", "journal-title": "Blood"}, {"key": "4_CR150", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1093/intimm/3.4.395", "volume": "3", "author": "E Yefenof", "year": "1991", "unstructured": "Yefenof E, Asjo B, Klein E (1991) Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity. Int Immunol 3:395\u2013401", "journal-title": "Int Immunol"}], "container-title": ["Symposium in Immunology V"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-79896-2_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T16:18:47Z", "timestamp": 1572884327000}, "score": 27.077412, "issued": {"date-parts": [[1996]]}, "ISBN": ["9783540600619", "9783642798962"], "references-count": 150, "URL": "http://dx.doi.org/10.1007/978-3-642-79896-2_4", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T16:31:17Z", "timestamp": 1574181077894}, "reference-count": 55, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 5, 1]], "date-time": "2006-05-01T00:00:00Z", "timestamp": 1146441600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 8, 22]], "date-time": "2013-08-22T00:00:00Z", "timestamp": 1377129600000}, "delay-in-days": 2670, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Virology"], "published-print": {"date-parts": [[2006, 5]]}, "DOI": "10.1016/j.virol.2005.12.029", "type": "journal-article", "created": {"date-parts": [[2006, 2, 4]], "date-time": "2006-02-04T15:52:41Z", "timestamp": 1139068361000}, "page": "341-353", "source": "Crossref", "is-referenced-by-count": 59, "title": ["Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype"], "prefix": "10.1016", "volume": "348", "author": [{"given": "Ranajit", "family": "Pal", "sequence": "first", "affiliation": []}, {"given": "Shixia", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "V.S.", "family": "Kalyanaraman", "sequence": "additional", "affiliation": []}, {"given": "B.C.", "family": "Nair", "sequence": "additional", "affiliation": []}, {"given": "Stephen", "family": "Whitney", "sequence": "additional", "affiliation": []}, {"given": "Timothy", "family": "Keen", "sequence": "additional", "affiliation": []}, {"given": "Lindsey", "family": "Hocker", "sequence": "additional", "affiliation": []}, {"given": "Lauren", "family": "Hudacik", "sequence": "additional", "affiliation": []}, {"given": "Nicolas", "family": "Rose", "sequence": "additional", "affiliation": []}, {"given": "Innocent", "family": "Mboudjeka", "sequence": "additional", "affiliation": []}, {"given": "Siyuan", "family": "Shen", "sequence": "additional", "affiliation": []}, {"given": "Te-Hui", "family": "Wu-Chou", "sequence": "additional", "affiliation": []}, {"given": "David", "family": "Montefiori", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Mascola", "sequence": "additional", "affiliation": []}, {"given": "Phillip", "family": "Markham", "sequence": "additional", "affiliation": []}, {"given": "Shan", "family": "Lu", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0042682205008548?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0042682205008548?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 18]], "date-time": "2019-01-18T17:22:37Z", "timestamp": 1547832157000}, "score": 26.538563, "issued": {"date-parts": [[2006, 5]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2006, 5]]}, "issue": "2"}, "alternative-id": ["S0042682205008548"], "URL": "http://dx.doi.org/10.1016/j.virol.2005.12.029", "ISSN": ["0042-6822"], "issn-type": [{"value": "0042-6822", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}